,Open,High,Low,Close,Adjusted Close,Volume,Dividend Amount,Split Coefficient,Symbol,AssetType,Name,Description,CIK,Exchange,Currency,Country,Sector,Industry,Address,OfficialSite,FiscalYearEnd,LatestQuarter,MarketCapitalization,EBITDA,PERatio,PEGRatio,BookValue,DividendPerShare,DividendYield,EPS,RevenuePerShareTTM,ProfitMargin,OperatingMarginTTM,ReturnOnAssetsTTM,ReturnOnEquityTTM,RevenueTTM,GrossProfitTTM,DilutedEPSTTM,QuarterlyEarningsGrowthYOY,QuarterlyRevenueGrowthYOY,AnalystTargetPrice,AnalystRatingStrongBuy,AnalystRatingBuy,AnalystRatingHold,AnalystRatingSell,AnalystRatingStrongSell,TrailingPE,ForwardPE,PriceToSalesRatioTTM,PriceToBookRatio,EVToRevenue,EVToEBITDA,Beta,52WeekHigh,52WeekLow,50DayMovingAverage,200DayMovingAverage,SharesOutstanding,SharesFloat,PercentInsiders,PercentInstitutions,DividendDate,ExDividendDate
2013-05-09,43.760000,44.330000,42.000000,42.110000,42.110000,19153400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-10,42.260000,42.970000,41.780000,42.390000,42.390000,2969700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-13,42.300000,43.370000,42.300000,43.320000,43.320000,1053100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-14,44.240000,44.749000,43.900000,44.430000,44.430000,2049800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-15,45.200000,45.740000,44.850000,45.500000,45.500000,2380500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-16,46.280000,46.500000,45.600100,45.850000,45.850000,1244600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-17,46.130000,46.210000,45.350000,45.520000,45.520000,920100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-20,45.450000,45.729900,45.260000,45.380000,45.380000,535800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-21,45.000000,45.300000,44.410000,45.050000,45.050000,668900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-22,45.140000,45.380000,44.110000,44.650000,44.650000,913200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-23,44.030000,45.150000,44.010000,45.000000,45.000000,881600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-24,44.970000,45.100000,44.835000,45.030000,45.030000,387200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-28,45.730000,45.810000,44.050000,45.430000,45.430000,719500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-29,45.430000,45.650000,44.130000,44.470000,44.470000,311100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-30,44.500000,44.500000,44.010000,44.250000,44.250000,298500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-05-31,44.120000,44.450000,44.040000,44.040000,44.040000,155000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-03,44.020000,44.580000,43.800000,44.580000,44.580000,394000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-04,44.480000,44.700000,43.060000,43.190000,43.190000,576800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-05,43.000000,43.190000,42.710000,42.850000,42.850000,967700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-06,42.710000,43.260000,42.680000,43.230000,43.230000,531100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-07,43.410000,43.760200,42.720000,42.970000,42.970000,471600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-10,43.030000,43.640000,42.960000,43.640000,43.640000,808400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-11,43.210000,44.900000,43.030000,43.950000,43.950000,329900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-12,43.750000,44.045000,42.890000,43.000000,43.000000,531500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-13,42.850000,43.090000,42.530000,42.900000,42.900000,500100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-14,43.000000,43.200000,42.790000,43.090000,43.090000,265300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-17,43.300000,43.620000,42.550000,43.530000,43.530000,472100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-18,44.000000,44.250000,43.650000,43.890000,43.890000,534600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-19,43.660000,44.190000,43.010000,43.790000,43.790000,343100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-20,43.310000,43.730000,42.500000,43.340000,43.340000,322800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-21,43.410000,44.280000,42.590000,44.190000,44.190000,655700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-24,43.570000,43.850000,42.315000,43.320000,43.320000,347900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-25,43.540000,43.740000,42.640000,43.000000,43.000000,214700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-26,43.240000,43.292000,42.020000,42.020000,42.020000,753300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-27,42.170000,42.710000,41.500000,42.330000,42.330000,675800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-06-28,42.290000,42.960000,42.260000,42.560000,42.560000,1400900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-01,42.560000,43.260000,42.280000,42.950000,42.950000,355000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-02,43.010000,43.500000,42.500000,43.060000,43.060000,256100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-03,42.990000,43.830000,42.250000,43.620000,43.620000,493900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-05,43.980000,44.000000,42.950000,43.240000,43.240000,197500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-08,43.060000,44.250000,42.906000,43.930000,43.930000,233700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-09,44.080000,44.320000,43.350000,43.690000,43.690000,115000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-10,43.900000,44.160000,43.280000,43.610000,43.610000,131300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-11,43.710000,43.840000,43.040000,43.270000,43.270000,337400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-12,43.190000,43.560000,43.010000,43.500000,43.500000,211500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-15,43.600000,43.850000,43.200000,43.650000,43.650000,215400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-16,43.650000,43.900000,42.820000,43.740000,43.740000,381900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-17,43.660000,44.340000,43.015000,43.830000,43.830000,540300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-18,43.880000,44.100000,43.670000,44.040000,44.040000,93700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-19,43.910000,44.240000,43.220000,44.070000,44.070000,135200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-22,44.000000,44.590000,43.590000,44.570000,44.570000,129300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-23,44.500000,44.600000,43.750000,44.320000,44.320000,244800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-24,44.300000,44.300000,43.210000,43.520000,43.520000,187200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-25,43.390000,43.750000,43.225000,43.480000,43.480000,217400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-26,43.230000,43.620000,43.160000,43.270000,43.270000,222700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-29,43.010000,43.720000,43.010000,43.470000,43.470000,37000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-30,43.410000,43.449900,43.000000,43.390000,43.390000,250400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-07-31,43.440000,45.480000,43.150000,44.850000,44.850000,733500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-01,46.710000,47.500000,45.500000,46.290000,46.290000,1155000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-02,46.490000,46.920000,45.160000,45.220000,45.220000,498200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-05,44.870000,45.420000,44.400000,45.330000,45.330000,323800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-06,45.090000,46.000000,45.040000,45.950000,45.950000,368500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-07,45.900000,45.900000,44.370000,45.540000,45.540000,292100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-08,45.630000,45.750000,45.140000,45.380000,45.380000,171800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-09,45.310000,45.650000,44.870100,45.640000,45.640000,119700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-12,45.440000,45.720000,45.201000,45.580000,45.580000,231400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-13,45.520000,45.646000,45.100100,45.380000,45.380000,217800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-14,45.250000,45.455000,45.030000,45.300000,45.300000,250600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-15,45.000000,45.090000,44.600000,44.750000,44.750000,177600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-16,44.700000,44.700000,44.010000,44.160000,44.160000,236400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-19,44.600000,45.000000,44.140000,44.320000,44.320000,314300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-20,44.420000,44.450000,43.570000,44.290000,44.290000,322700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-21,44.210000,44.210000,43.680000,44.000000,44.000000,193400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-22,44.000000,44.210000,43.660000,43.660000,43.660000,120800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-23,43.660000,43.805000,43.500000,43.530000,43.530000,116000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-26,43.550000,43.870000,43.350000,43.430000,43.430000,156200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-27,43.220000,43.460000,42.780000,43.120000,43.120000,226000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-28,43.050000,44.250000,43.050000,43.980000,43.980000,216000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-29,44.000000,44.220000,43.610000,43.900000,43.900000,170400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-08-30,43.890000,43.890000,42.790000,43.260000,43.260000,205000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-03,43.480000,43.600000,42.950000,43.100000,43.100000,193400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-04,43.050000,43.660000,42.770000,43.230000,43.230000,339100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-05,43.210000,43.390000,43.000000,43.190000,43.190000,62700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-06,43.140000,43.490000,42.700000,42.820000,42.820000,194100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-09,42.820000,43.310000,42.710000,43.150000,43.150000,249700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-10,43.150000,43.800000,42.868000,43.770000,43.770000,421700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-11,43.770000,44.640000,43.010000,43.730000,43.730000,444200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-12,43.810000,45.140000,43.516000,44.470000,44.470000,506500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-13,44.440000,44.570800,43.810000,44.370000,44.370000,167000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-16,44.540000,44.800000,43.972800,44.450000,44.450000,224400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-17,44.940000,45.740000,44.340000,44.770000,44.770000,284500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-18,44.800000,45.530000,44.170000,45.090000,45.090000,214700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-19,45.010000,45.010000,43.850000,44.000000,44.000000,483100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-20,43.940000,44.860000,43.870000,44.720000,44.720000,669900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-23,44.730000,45.000000,43.320000,44.860000,44.860000,456400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-24,45.000000,45.200000,44.650000,44.760000,44.760000,505000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-25,44.810000,45.090000,44.500000,44.690000,44.690000,174400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-26,44.660000,45.310000,44.610000,45.100000,45.100000,230500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-27,44.910000,45.070500,44.450000,44.930000,44.930000,276400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-09-30,44.570000,45.110000,44.010000,44.880000,44.880000,203900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-01,44.810000,45.500000,44.260000,44.670000,44.670000,543600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-02,44.400000,44.790000,43.930000,44.040000,44.040000,318000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-03,43.970000,44.070000,43.060000,43.250000,43.250000,257300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-04,43.090000,44.170000,42.970000,43.980000,43.980000,330200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-07,43.740000,44.125000,42.500000,42.550000,42.550000,499300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-08,42.530000,42.840000,41.100000,41.580000,41.580000,1117700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-09,42.390000,43.180000,41.950000,42.220000,42.220000,508900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-10,42.690000,42.820000,42.130000,42.570000,42.570000,234600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-11,42.430000,42.615000,42.000000,42.230000,42.230000,312900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-14,42.090000,42.350000,41.720000,42.020000,42.020000,396800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-15,42.050000,42.700000,41.820000,41.990000,41.990000,153100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-16,42.070000,43.250000,42.070000,43.120000,43.120000,310400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-17,42.920000,43.896000,42.900000,43.530000,43.530000,264300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-18,43.660000,43.950000,43.520000,43.930000,43.930000,181500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-21,43.850000,43.990000,43.600000,43.980000,43.980000,248000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-22,43.990000,44.140000,43.580000,44.110000,44.110000,288600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-23,44.040000,44.040000,43.535000,43.810000,43.810000,81500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-24,43.760000,44.550000,43.760000,44.550000,44.550000,273600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-25,44.520000,44.520000,43.990000,44.310000,44.310000,175900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-28,44.390000,44.547500,43.890000,43.900000,43.900000,184400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-29,43.890000,44.110000,43.620000,43.770000,43.770000,187000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-30,43.720000,44.010000,42.770000,43.380000,43.380000,654000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-10-31,43.750000,44.209000,40.100000,41.990000,41.990000,1466600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-01,42.750000,44.180000,42.470000,43.430000,43.430000,1490100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-04,43.690000,44.300000,43.680000,44.200000,44.200000,336100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-05,44.140000,44.350000,43.650000,44.090000,44.090000,325600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-06,44.080000,44.269900,43.590000,44.000000,44.000000,307300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-07,44.010000,44.190000,43.800000,44.050000,44.050000,482100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-08,43.950000,44.240000,43.530000,44.090000,44.090000,338700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-11,44.100000,44.420000,43.620000,43.980000,43.980000,253700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-12,44.000000,44.380000,43.200000,44.140000,44.140000,361700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-13,43.930000,44.420000,43.550000,44.370000,44.370000,261000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-14,44.300000,44.300000,43.770000,43.970000,43.970000,354400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-15,44.000000,44.210000,43.850000,43.980000,43.980000,320100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-18,43.640000,43.640000,42.690000,43.310000,43.310000,1040500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-19,42.960000,43.240000,42.660000,42.860000,42.860000,682900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-20,42.510000,43.230000,42.500000,42.880000,42.880000,926400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-21,42.750000,43.260100,42.200000,43.250000,43.250000,896300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-22,43.190000,43.450000,42.950000,43.110000,43.110000,359800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-25,43.000000,43.400000,42.690000,42.700000,42.700000,446200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-26,42.800000,43.360000,42.750000,43.000000,43.000000,423100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-27,43.110000,43.480000,42.760000,42.990000,42.990000,266700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-11-29,43.240000,43.500000,43.040000,43.190000,43.190000,101300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-02,43.300000,43.390000,42.630000,42.790000,42.790000,397300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-03,42.470000,42.747000,42.300000,42.350000,42.350000,480000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-04,42.300000,42.310000,41.790000,41.940000,41.940000,420100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-05,41.890000,42.058000,41.430000,41.870000,41.870000,419900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-06,41.960000,42.180000,41.640000,42.030000,42.030000,381800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-09,42.100000,42.970000,42.020000,42.740000,42.740000,428400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-10,43.230000,44.520000,43.230000,43.730000,43.730000,1564200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-11,44.150000,44.270000,43.470000,43.770000,43.770000,727000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-12,43.640000,45.240000,43.640000,45.070000,45.070000,1052600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-13,45.000000,45.260000,44.350000,44.970000,44.970000,579100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-16,44.970000,45.600000,44.360000,45.150000,45.150000,600800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-17,45.380000,45.550000,44.740000,45.220000,45.220000,714600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-18,45.350000,45.740000,44.760000,45.680000,45.680000,781400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-19,45.350000,45.799000,45.025000,45.160000,45.160000,441400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-20,44.680000,46.280000,43.820000,45.420000,45.420000,1581600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-23,45.920000,46.545000,45.820000,46.200000,46.200000,398700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-24,46.360000,46.699000,45.936000,46.400000,46.400000,154200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-26,46.510000,46.750000,46.114000,46.480000,46.480000,272500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-27,46.470000,46.581800,46.091000,46.400000,46.400000,130600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-30,46.400000,46.690000,46.000000,46.450000,46.450000,167700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2013-12-31,46.580000,46.580000,45.960000,46.340000,46.340000,215600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-02,46.110000,46.590000,45.640000,45.800000,45.800000,274600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-03,45.940000,46.540000,45.660000,46.290000,46.290000,261400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-06,46.460000,46.550000,45.990000,46.030000,46.030000,240900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-07,46.500000,47.480000,46.476000,46.790000,46.790000,556800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-08,46.810000,47.700000,46.781400,47.420000,47.420000,384000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-09,47.500000,47.900000,47.500000,47.840000,47.840000,285400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-10,47.960000,48.756000,47.840000,48.610000,48.610000,522300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-13,48.660000,49.930000,48.480100,49.160000,49.160000,687800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-14,49.320000,49.650000,48.890000,49.000000,49.000000,221200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-15,49.340000,49.730000,49.030000,49.500000,49.500000,410500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-16,49.430000,50.000000,49.194000,49.780000,49.780000,368900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-17,49.890000,50.490000,48.160000,48.980000,48.980000,763900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-21,51.950000,52.000000,47.660000,48.150000,48.150000,988300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-22,48.140000,48.820000,47.680000,48.010000,48.010000,426200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-23,48.010000,48.050000,47.460000,47.740000,47.740000,312100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-24,47.450000,47.802000,46.000000,46.210000,46.210000,815100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-27,46.300000,46.790000,45.250000,46.540000,46.540000,437100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-28,46.800000,47.820000,46.435000,47.300000,47.300000,361400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-29,47.070000,47.350000,46.230000,46.430000,46.430000,277300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-30,46.790000,47.960000,46.500000,47.700000,47.700000,321800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-01-31,47.230000,47.700000,46.830000,47.630000,47.630000,228000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-03,47.220000,47.660000,45.845000,46.430000,46.430000,455300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-04,46.770000,47.084000,46.383000,46.610000,46.610000,226300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-05,46.580000,48.390000,46.343700,48.370000,48.370000,607000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-06,48.740000,49.510000,48.294700,49.000000,49.000000,864900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-07,49.100000,49.409900,47.870000,48.230000,48.230000,468700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-10,48.100000,48.949900,47.980000,48.610000,48.610000,356900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-11,48.730000,49.290000,48.150000,49.150000,49.150000,375000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-12,49.050000,49.580000,48.890000,49.440000,49.440000,431500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-13,50.000000,52.240000,49.850000,52.200000,52.200000,1732600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-14,52.200000,53.170000,51.860000,53.150000,53.150000,1273800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-18,53.000000,54.310000,52.850000,53.770000,53.770000,743100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-19,53.680000,55.000000,53.280400,54.940000,54.940000,742700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-20,54.480000,54.950000,53.960000,54.540000,54.540000,750000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-21,54.790000,54.858000,53.870000,53.930000,53.930000,572400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-24,54.000000,54.000000,53.000000,53.630000,53.630000,414500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-25,53.520000,53.750000,52.700000,53.260000,53.260000,266700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-26,53.400000,53.650000,52.900000,53.620000,53.620000,260800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-27,53.290000,54.410000,53.080000,53.500000,53.500000,345100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-02-28,53.510000,54.570000,53.350000,54.150000,54.150000,398900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-03,53.600000,53.600000,52.070000,52.870000,52.870000,477700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-04,53.090000,54.399000,53.090000,54.060000,54.060000,314100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-05,54.320000,54.780000,53.700000,54.120000,54.120000,535500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-06,54.520000,54.995000,53.821000,54.480000,54.480000,556500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-07,54.580000,54.769900,53.970000,54.110000,54.110000,290000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-10,53.940000,54.360000,53.110000,54.300000,54.300000,723500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-11,54.180000,54.300000,52.760000,52.810000,52.810000,926900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-12,52.100000,54.080000,51.780000,52.820000,52.820000,1528900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-13,51.590000,52.000000,50.410000,51.240000,51.240000,12618800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-14,51.070000,52.270000,51.000000,52.170000,52.170000,1911000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-17,52.210000,52.680000,52.200000,52.450000,52.450000,1349200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-18,52.550000,53.332900,52.480100,52.960000,52.960000,824700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-19,53.000000,53.668000,52.450000,52.720000,52.720000,738300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-20,52.410000,53.170000,52.351000,52.920000,52.920000,1087700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-21,53.020000,53.020000,50.070000,51.020000,51.020000,2305000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-24,51.330000,51.730000,50.220000,50.440000,50.440000,542700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-25,50.480000,51.270000,49.660000,49.800000,49.800000,886800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-26,50.070000,50.480000,49.810000,50.010000,50.010000,692500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-27,50.060000,50.490000,49.780000,50.060000,50.060000,292200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-28,50.130000,50.549900,49.900500,49.970000,49.970000,463400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-03-31,50.300000,51.090000,49.650000,50.770000,50.770000,449500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-01,50.300000,51.440000,49.690000,51.110000,51.110000,841800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-02,51.000000,51.500000,50.510000,51.070000,51.070000,732100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-03,51.340000,51.500000,50.690000,50.940000,50.940000,425900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-04,51.220000,51.220000,49.830400,50.110000,50.110000,729200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-07,49.940000,50.310000,49.200100,49.710000,49.710000,634600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-08,49.570000,51.150000,49.490000,51.050000,51.050000,592900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-09,51.070000,51.560000,51.000000,51.340000,51.340000,800900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-10,51.340000,51.870000,51.340000,51.400000,51.400000,927100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-11,51.000000,51.000000,50.060000,50.280000,50.280000,666900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-14,50.840000,51.200000,50.120000,50.550000,50.550000,544300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-15,50.800000,51.072000,49.690000,50.670000,50.670000,526500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-16,50.880000,51.210000,50.570000,50.600000,50.600000,384600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-17,50.630000,50.740000,50.170000,50.220000,50.220000,236400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-21,50.370000,50.750000,50.250000,50.680000,50.680000,542800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-22,50.750000,50.750000,49.900000,49.950000,49.950000,745400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-23,49.920000,50.240000,49.160000,49.470000,49.470000,430500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-24,49.920000,50.350000,49.010000,49.940000,49.940000,382100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-25,49.900000,50.050000,49.300000,49.390000,49.390000,397300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-28,49.510000,49.920000,46.420000,47.520000,47.520000,1326800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-29,47.500000,47.680000,46.950000,47.580000,47.580000,866700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-04-30,47.620000,47.930000,46.270000,47.130000,47.130000,1390700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-01,49.990000,49.990000,48.320000,48.760000,48.760000,1786300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-02,49.170000,49.780000,47.030000,47.320000,47.320000,1399500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-05,47.240000,47.410000,46.855000,46.990000,46.990000,616000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-06,46.940000,47.400000,46.650000,46.750000,46.750000,596100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-07,46.630000,47.400000,46.270000,47.350000,47.350000,644000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-08,47.240000,47.750000,46.800000,46.990000,46.990000,497100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-09,46.900000,47.870000,46.660000,47.540000,47.540000,520500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-12,47.730000,48.040000,47.490000,47.870000,47.870000,729400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-13,47.940000,47.940000,47.020000,47.500000,47.500000,496500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-14,47.490000,48.250000,47.265000,47.760000,47.760000,574600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-15,47.910000,49.250000,47.910000,49.220000,49.220000,882300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-16,49.010000,49.740000,48.930000,49.600000,49.600000,777900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-19,49.500000,50.214000,49.240000,49.810000,49.810000,631200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-20,49.710000,50.425000,49.620000,50.400000,50.400000,915100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-21,50.480000,51.070000,50.130000,50.640000,50.640000,669000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-22,50.410000,51.060000,49.990000,50.890000,50.890000,418700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-23,50.710000,51.240000,50.660000,51.240000,51.240000,300800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-27,51.220000,51.600000,51.160000,51.260000,51.260000,459800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-28,51.190000,51.500000,50.850000,50.870000,50.870000,597400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-29,51.050000,51.200000,50.530000,50.870000,50.870000,493200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-05-30,51.130000,51.750000,50.060100,50.980000,50.980000,2637600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-02,50.900000,51.340000,50.550000,51.100000,51.100000,380400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-03,51.000000,51.850000,50.880000,51.440000,51.440000,452500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-04,51.240000,52.800000,51.030000,52.630000,52.630000,1229600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-05,52.900000,53.000000,52.460000,52.810000,52.810000,535100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-06,53.000000,53.080000,52.420000,52.990000,52.990000,462500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-09,52.930000,53.220000,52.880000,52.980000,52.980000,452900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-10,52.680000,52.930000,52.470000,52.670000,52.670000,345100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-11,52.500000,52.650000,52.300000,52.340000,52.340000,260100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-12,52.280000,52.460000,51.870000,52.140000,52.140000,243900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-13,52.090000,52.090000,51.500000,51.610000,51.610000,308300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-16,51.500000,51.980000,51.000000,51.050000,51.050000,653200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-17,51.000000,51.770000,50.800000,51.250000,51.250000,681600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-18,51.310000,51.440000,51.020000,51.250000,51.250000,378100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-19,51.420000,52.980000,51.080000,52.930000,52.930000,684900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-20,52.850000,53.530000,52.770000,53.330000,53.330000,537100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-23,53.240000,53.550000,52.820000,52.950000,52.950000,382700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-24,52.700000,53.275000,52.424000,52.880000,52.880000,618000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-25,52.660000,52.980000,52.330000,52.690000,52.690000,557500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-26,52.580000,52.580000,51.820000,52.280000,52.280000,475900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-27,52.250000,52.460000,51.550000,51.920000,51.920000,1900900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-06-30,52.020000,53.500000,51.920000,53.290000,53.290000,512900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-01,53.300000,53.835000,53.030000,53.560000,53.560000,487600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-02,53.630000,54.449000,53.190000,54.420000,54.420000,679900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-03,54.400000,55.000000,53.490000,54.960000,54.960000,1152200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-07,54.470000,55.470000,54.440000,55.300000,55.300000,902200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-08,55.040000,55.040000,54.300000,54.920000,54.920000,645700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-09,54.970000,55.170000,54.850000,55.050000,55.050000,615700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-10,54.630000,55.680000,54.180000,55.550000,55.550000,433700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-11,55.410000,55.650000,55.150000,55.390000,55.390000,379200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-14,55.400000,55.400000,54.710000,55.020000,55.020000,536600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-15,55.190000,55.540000,55.040000,55.100000,55.100000,515300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-16,55.400000,55.400000,54.720000,54.900000,54.900000,403700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-17,54.770000,55.130000,54.380000,54.480000,54.480000,256400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-18,54.680000,55.280000,54.652000,55.210000,55.210000,246500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-21,55.130000,55.430000,54.710000,55.270000,55.270000,301100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-22,55.340000,55.650000,54.450000,54.970000,54.970000,363100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-23,54.960000,55.300000,54.880000,55.000000,55.000000,304700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-24,55.000000,55.155000,54.560000,54.840000,54.840000,305000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-25,54.750000,55.260000,54.450000,54.990000,54.990000,199300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-28,54.770000,55.270000,54.440000,54.800000,54.800000,336100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-29,54.860000,56.355000,54.430000,55.940000,55.940000,619600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-30,56.280000,57.330000,55.430000,56.820000,56.820000,1027000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-07-31,54.850000,55.240000,53.420000,54.930000,54.930000,1113400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-01,55.520000,56.310000,54.870000,55.040000,55.040000,543000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-04,55.230000,55.410000,54.660000,55.410000,55.410000,518600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-05,55.100000,55.610000,54.790000,55.530000,55.530000,397400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-06,55.240000,55.500000,54.820000,55.060000,55.060000,367600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-07,55.460000,55.830000,54.990000,55.760000,55.760000,529500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-08,55.870000,56.036000,55.195000,55.850000,55.850000,385700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-11,55.850000,56.507900,55.750000,55.940000,55.940000,337800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-12,55.890000,56.310000,55.300000,56.100000,56.100000,435600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-13,56.130000,56.500000,55.852500,56.390000,56.390000,263900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-14,56.860000,57.240000,56.600000,57.170000,57.170000,332200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-15,57.170000,57.170000,56.530000,57.020000,57.020000,323600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-18,57.320000,57.650000,56.760000,57.080000,57.080000,463500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-19,56.650000,56.862000,55.640000,56.130000,56.130000,728700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-20,55.990000,56.360000,55.770000,56.050000,56.050000,310200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-21,56.080000,56.390000,55.845000,56.340000,56.340000,310000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-22,56.310000,56.490000,55.671200,55.740000,55.740000,253600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-25,55.900000,56.080000,55.260000,55.490000,55.490000,446900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-26,55.720000,56.090000,55.190000,55.850000,55.850000,361000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-27,56.000000,56.890000,55.930000,56.760000,56.760000,321400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-28,56.680000,57.000000,56.270100,56.360000,56.360000,206900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-08-29,56.600000,56.725000,55.847500,56.120000,56.120000,348000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-02,56.320000,56.360000,55.760000,55.880000,55.880000,367900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-03,55.940000,56.480000,55.880000,55.980000,55.980000,774300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-04,56.000000,56.620000,55.710000,56.270000,56.270000,853500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-05,55.970000,56.120000,55.350000,55.690000,55.690000,511900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-08,56.090000,56.245000,55.876000,55.960000,55.960000,496100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-09,56.120000,56.288200,55.360000,55.540000,55.540000,537400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-10,55.820000,56.870000,55.386000,56.500000,56.500000,614300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-11,56.440000,58.887000,56.440000,58.670000,58.670000,962900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-12,58.670000,58.770000,57.170000,57.570000,57.570000,659000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-15,57.680000,57.950000,57.110000,57.250000,57.250000,467900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-16,57.360000,57.850000,56.620000,57.160000,57.160000,527500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-17,57.290000,57.480000,56.110000,56.220000,56.220000,595000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-18,56.430000,57.230000,56.135000,57.000000,57.000000,533100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-19,57.360000,57.500000,56.930000,57.320000,57.320000,1176200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-22,57.320000,57.490000,56.280000,56.290000,56.290000,453764,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-23,56.410000,56.730000,55.540000,55.760000,55.760000,430639,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-24,55.970000,57.010000,55.610000,56.980000,56.980000,413519,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-25,56.920000,56.970000,55.590000,55.830000,55.830000,340884,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-26,56.190000,56.980000,55.590000,56.920000,56.920000,553742,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-29,56.580000,57.730000,56.310000,57.200000,57.200000,542400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-09-30,57.410000,57.529900,55.710000,55.780000,55.780000,553180,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-01,56.260000,56.499900,54.080000,54.560000,54.560000,959662,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-02,54.750000,55.180000,54.340000,54.570000,54.570000,820037,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-03,54.810000,56.550000,54.770000,56.190000,56.190000,961556,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-06,56.450000,57.130000,55.190000,55.380000,55.380000,482990,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-07,55.130000,55.220000,54.497300,54.600000,54.600000,320688,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-08,54.640000,55.320000,53.750000,55.300000,55.300000,402630,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-09,55.080000,55.520000,54.190000,54.640000,54.640000,408825,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-10,53.550000,55.530000,53.130000,53.200000,53.200000,527162,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-13,53.400000,53.630000,52.490000,52.600000,52.600000,404570,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-14,52.960000,53.600000,52.060000,52.910000,52.910000,415611,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-15,52.500000,53.040000,51.090000,52.540000,52.540000,517410,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-16,52.640000,54.300000,52.440000,54.110000,54.110000,802903,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-17,54.740000,55.830000,54.610000,55.300000,55.300000,2055939,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-20,55.040000,55.410000,54.260000,54.780000,54.780000,372529,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-21,55.280000,56.735000,55.070000,56.500000,56.500000,523021,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-22,56.520000,57.000000,56.150000,56.550000,56.550000,315431,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-23,57.000000,57.460000,56.800000,56.990000,56.990000,343359,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-24,56.940000,58.530000,56.870000,57.560000,57.560000,591942,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-27,57.690000,57.955000,57.330000,57.530000,57.530000,297095,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-28,57.930000,57.940000,57.180000,57.740000,57.740000,341949,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-29,58.000000,58.000000,57.270000,57.990000,57.990000,427342,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-30,57.750000,57.750000,55.260000,56.300000,56.300000,1309396,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-10-31,56.330000,58.550000,56.150000,58.540000,58.540000,1094260,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-03,59.000000,60.710000,58.410000,59.650000,59.650000,1558223,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-04,59.500000,59.900000,58.720000,58.850000,58.850000,826060,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-05,57.270000,57.485000,56.640000,57.060000,57.060000,4117077,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-06,57.060000,58.050000,57.060000,57.950000,57.950000,1435459,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-07,58.030000,58.120000,56.970000,57.210000,57.210000,903086,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-10,57.680000,57.890000,57.050000,57.220000,57.220000,494069,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-11,57.240000,57.490000,56.420000,56.810000,56.810000,520113,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-12,56.710000,56.890000,56.020000,56.410000,56.410000,647772,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-13,56.530000,56.790000,56.270000,56.390000,56.390000,533282,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-14,56.470000,56.640000,54.770000,55.830000,55.830000,1095911,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-17,55.570000,56.580000,55.370000,56.430000,56.430000,1064260,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-18,56.470000,57.490000,56.290000,57.330000,57.330000,882801,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-19,57.410000,57.830000,57.290000,57.720000,57.720000,831240,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-20,57.320000,58.200000,57.170000,57.750000,57.750000,1180539,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-21,58.270000,58.540000,57.790000,57.860000,57.860000,908524,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-24,58.000000,58.190000,57.330000,57.590000,57.590000,714558,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-25,57.850000,58.030000,57.210000,57.750000,57.750000,691170,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-26,57.650000,58.200000,57.270000,57.960000,57.960000,365017,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-11-28,58.070000,58.170000,57.550000,57.820000,57.820000,230031,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-01,57.320000,57.700000,56.120000,56.750000,56.750000,591174,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-02,57.020000,57.830000,56.920000,57.540000,57.540000,417707,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-03,57.780000,58.450000,57.453400,58.250000,58.250000,696332,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-04,58.000000,58.320000,57.000000,57.400000,57.400000,402571,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-05,57.680000,58.000000,56.900000,57.370000,57.370000,329533,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-08,57.170000,57.630000,56.440000,57.000000,57.000000,320798,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-09,57.620000,58.100000,57.120000,57.790000,57.790000,1140795,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-10,58.490000,58.490000,57.150000,57.210000,57.210000,541609,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-11,57.360000,58.040000,57.107000,57.480000,57.480000,1232494,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-12,57.000000,58.180000,57.000000,57.370000,57.370000,1658163,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-15,57.810000,58.250000,56.780000,57.050000,57.050000,1104304,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-16,56.790000,57.670000,56.790000,57.170000,57.170000,1147993,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-17,57.170000,58.300000,57.110000,57.540000,57.540000,1751700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-18,58.570000,59.490000,57.430000,59.380000,59.380000,1261329,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-19,60.000000,60.475000,59.580000,60.390000,60.390000,1333041,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-22,60.280000,60.650000,59.770000,60.090000,60.090000,399490,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-23,60.650000,60.650000,59.112900,59.470000,59.470000,462126,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-24,59.420000,60.000000,59.180000,59.480000,59.480000,221680,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-26,59.560000,60.790000,59.380000,60.660000,60.660000,457847,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-29,60.620000,60.620000,59.560000,59.950000,59.950000,318703,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-30,59.950000,60.250000,59.480000,59.690000,59.690000,261376,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2014-12-31,59.650000,60.118000,58.800000,58.870000,58.870000,377867,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-02,59.140000,59.860000,58.780000,59.110000,59.110000,458476,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-05,58.460000,59.380000,58.130000,58.410000,58.410000,638305,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-06,58.630000,58.630000,56.460000,57.070000,57.070000,965980,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-07,57.820000,58.200000,57.500000,57.770000,57.770000,737682,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-08,58.440000,59.240000,58.170000,59.200000,59.200000,436058,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-09,59.330000,59.750000,58.460000,58.820000,58.820000,454409,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-12,59.060000,59.455000,58.640000,59.060000,59.060000,388900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-13,59.440000,60.000000,58.910000,59.490000,59.490000,612226,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-14,59.040000,59.480000,58.625700,59.100000,59.100000,354635,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-15,59.240000,60.500000,58.960000,59.040000,59.040000,557847,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-16,58.580000,59.980000,58.550000,59.580000,59.580000,967193,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-20,60.000000,60.100000,59.370000,59.950000,59.950000,573455,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-21,59.860000,60.640000,59.577000,59.780000,59.780000,552451,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-22,60.080000,60.730000,59.240000,60.540000,60.540000,430594,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-23,60.530000,61.710000,60.530000,60.970000,60.970000,645450,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-26,60.790000,62.220000,60.554000,61.960000,61.960000,733035,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-27,61.350000,62.124900,60.860100,61.900000,61.900000,410206,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-28,62.250000,62.730000,61.440000,61.660000,61.660000,472874,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-29,61.650000,61.810000,60.600000,61.760000,61.760000,364326,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-01-30,61.600000,61.600000,60.320000,60.500000,60.500000,487514,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-02,60.310000,60.650000,59.570000,60.560000,60.560000,559913,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-03,60.610000,60.806000,59.740000,60.270000,60.270000,550448,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-04,59.960000,61.000000,59.780000,60.750000,60.750000,487846,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-05,60.850000,61.310000,60.600000,61.210000,61.210000,305347,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-06,61.220000,61.640000,60.290000,60.460000,60.460000,289932,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-09,60.360000,60.510000,59.000000,59.240000,59.240000,405353,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-10,59.610000,60.230000,58.800000,60.110000,60.110000,712142,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-11,60.210000,61.140000,59.730000,60.680000,60.680000,770847,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-12,63.350000,64.000000,62.760000,63.250000,63.250000,1192736,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-13,64.020000,64.190000,63.210000,63.310000,63.310000,596422,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-17,63.310000,64.130000,62.520000,64.010000,64.010000,1371160,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-18,64.600000,64.630000,63.730000,64.610000,64.610000,463208,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-19,64.440000,65.200000,63.910000,64.520000,64.520000,567934,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-20,64.240000,65.150000,63.540000,65.150000,65.150000,587195,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-23,65.100000,66.280000,64.900000,64.990000,64.990000,582326,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-24,65.200000,65.300000,64.300000,64.490000,64.490000,506253,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-25,64.660000,65.340000,64.310000,65.030000,65.030000,427961,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-26,64.900000,65.310000,64.750000,64.950000,64.950000,317868,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-02-27,64.910000,65.360000,64.570000,64.980000,64.980000,317042,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-02,65.170000,65.900000,64.590000,65.540000,65.540000,530946,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-03,65.560000,65.640000,65.030000,65.540000,65.540000,438218,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-04,65.390000,65.400000,64.600000,64.930000,64.930000,368305,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-05,65.160000,65.990000,64.982000,65.700000,65.700000,412956,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-06,65.600000,65.990000,64.870000,65.300000,65.300000,277597,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-09,65.450000,65.770000,64.879900,65.340000,65.340000,277187,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-10,65.000000,65.000000,64.000000,64.440000,64.440000,494227,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-11,64.780000,65.280000,64.580000,64.980000,64.980000,455751,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-12,65.080000,65.770000,65.080000,65.340000,65.340000,473026,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-13,65.370000,66.140000,65.030000,66.050000,66.050000,512240,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-16,66.300000,66.900000,66.120000,66.570000,66.570000,443121,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-17,66.340000,66.840000,65.780000,66.800000,66.800000,355824,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-18,66.810000,66.970000,66.230100,66.750000,66.750000,310206,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-19,66.670000,66.885000,66.320000,66.870000,66.870000,310556,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-20,67.450000,67.590000,66.790000,67.250000,67.250000,882878,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-23,67.290000,68.000000,67.000000,67.970000,67.970000,624553,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-24,67.990000,68.520000,67.390000,67.450000,67.450000,665917,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-25,67.690000,67.910000,66.250000,66.310000,66.310000,534178,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-26,64.770000,66.600000,63.620000,66.290000,66.290000,981782,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-27,66.300000,67.370000,66.250000,67.260000,67.260000,600085,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-30,67.960000,68.200000,67.565000,68.000000,68.000000,426407,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-03-31,68.900000,69.970000,66.840000,66.970000,66.970000,1052059,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-01,66.460000,67.930000,66.150000,67.870000,67.870000,789886,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-02,67.880000,67.980000,66.230000,66.390000,66.390000,469605,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-06,65.970000,66.880000,65.770000,66.460000,66.460000,532627,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-07,66.450000,67.340000,66.080000,66.200000,66.200000,546380,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-08,66.140000,67.290000,66.080000,67.170000,67.170000,437953,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-09,67.090000,67.430000,66.710000,67.410000,67.410000,557742,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-10,67.430000,67.770000,67.130000,67.630000,67.630000,389314,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-13,67.580000,67.990000,67.282000,67.870000,67.870000,326584,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-14,67.900000,67.900000,67.081000,67.210000,67.210000,270669,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-15,67.500000,67.770000,67.040000,67.160000,67.160000,289335,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-16,67.150000,67.720000,66.870000,67.480000,67.480000,302772,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-17,66.950000,67.460000,66.240000,66.690000,66.690000,556107,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-20,67.100000,67.100000,66.460000,66.490000,66.490000,255188,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-21,66.750000,66.960000,66.290000,66.700000,66.700000,258051,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-22,66.730000,66.880000,65.990000,66.450000,66.450000,575449,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-23,66.790000,67.740000,66.480000,67.690000,67.690000,733456,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-24,68.500000,70.000000,67.810000,69.090000,69.090000,951006,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-27,69.090000,69.330000,68.630000,68.900000,68.900000,865615,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-28,69.060000,69.980000,68.240000,69.310000,69.310000,1151652,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-29,64.510000,68.830000,64.250000,68.470000,68.470000,1577908,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-04-30,68.110000,68.230000,65.580000,65.880000,65.880000,970855,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-01,65.940000,67.480000,65.520000,67.300000,67.300000,1176438,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-04,67.280000,68.520000,66.024000,66.230000,66.230000,1077954,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-05,66.200000,66.210000,64.530000,64.590000,64.590000,665388,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-06,65.070000,65.150000,64.260000,64.900000,64.900000,552378,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-07,65.190000,65.750000,64.680100,64.860000,64.860000,730926,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-08,65.510000,65.910000,64.620000,64.850000,64.850000,916387,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-11,64.700000,65.080000,64.360000,64.360000,64.360000,1071273,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-12,64.010000,64.920000,63.630000,64.470000,64.470000,925474,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-13,64.920000,65.710000,64.600000,65.480000,65.480000,789827,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-14,65.700000,66.160000,64.660000,65.670000,65.670000,3189503,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-15,66.090000,67.190000,65.850000,67.140000,67.140000,1572184,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-18,67.500000,67.942500,66.877500,67.530000,67.530000,1012823,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-19,67.900000,68.630000,67.640000,68.370000,68.370000,839671,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-20,68.720000,69.090000,67.680000,68.810000,68.810000,731498,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-21,68.920000,68.990000,68.290000,68.710000,68.710000,675144,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-22,68.530000,69.930000,68.480000,69.700000,69.700000,991755,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-26,70.190000,70.630000,69.160000,69.270000,69.270000,1311017,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-27,69.630000,70.560000,69.390000,70.520000,70.520000,833802,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-28,70.180000,70.770000,69.900000,70.590000,70.590000,475815,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-05-29,70.640000,70.794000,69.440000,69.710000,69.710000,1109790,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-01,69.710000,70.250000,69.570000,70.040000,70.040000,522296,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-02,69.950000,70.050000,68.770000,69.680000,69.680000,833899,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-03,70.140000,70.210000,69.460000,69.640000,69.640000,381522,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-04,69.350000,70.190000,69.210000,69.670000,69.670000,364945,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-05,69.640000,70.070000,68.980000,69.710000,69.710000,595433,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-08,69.880000,70.340000,69.360000,69.450000,69.450000,270729,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-09,69.290000,69.720000,68.230000,69.430000,69.430000,372489,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-10,69.550000,69.910000,69.080000,69.420000,69.420000,613149,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-11,69.710000,69.890000,69.170000,69.860000,69.860000,513315,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-12,69.470000,70.700000,68.780000,70.030000,70.030000,398742,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-15,69.770000,69.960000,69.060000,69.690000,69.690000,400799,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-16,69.740000,70.640000,69.540000,70.580000,70.580000,422646,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-17,70.930000,70.930000,70.080000,70.780000,70.780000,466825,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-18,70.720000,71.535000,70.492000,71.110000,71.110000,414432,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-19,71.400000,71.910000,70.700100,71.850000,71.850000,669794,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-22,72.160000,72.730000,71.600000,72.720000,72.720000,702506,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-23,72.630000,73.520000,72.480000,73.510000,73.510000,1005703,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-24,73.270000,73.760000,72.740000,72.900000,72.900000,1131020,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-25,73.440000,73.620000,72.700000,73.490000,73.490000,862568,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-26,73.450000,73.820000,72.830000,73.250000,73.250000,1974635,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-29,72.860000,73.240000,71.875000,72.080000,72.080000,689672,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-06-30,72.410000,72.960000,71.940000,72.610000,72.610000,1076120,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-01,72.750000,73.436400,72.420000,72.970000,72.970000,627865,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-02,72.060000,73.100000,72.060000,72.800000,72.800000,428754,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-06,72.480000,72.910000,71.990000,72.620000,72.620000,702370,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-07,72.900000,72.900000,71.900000,72.860000,72.860000,595275,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-08,72.500000,72.700000,71.455000,71.670000,71.670000,590037,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-09,72.590000,72.650000,71.940000,72.160000,72.160000,389135,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-10,74.610000,74.970000,73.700000,74.170000,74.170000,507111,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-13,74.950000,75.300000,74.060000,75.240000,75.240000,673401,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-14,75.450000,76.120000,75.080000,76.070000,76.070000,489804,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-15,76.280000,76.280000,75.600000,75.930000,75.930000,526579,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-16,76.440000,77.170000,75.860000,76.720000,76.720000,490531,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-17,76.750000,76.910000,76.150000,76.860000,76.860000,406963,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-20,77.210000,77.210000,76.140000,76.410000,76.410000,530608,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-21,76.070000,76.170000,74.440000,75.290000,75.290000,538679,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-22,75.600000,76.350000,75.010000,76.230000,76.230000,499103,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-23,76.430000,76.430000,75.350000,75.640000,75.640000,378627,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-24,75.560000,75.750000,74.800000,74.940000,74.940000,386356,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-27,74.630000,75.180000,74.330000,74.580000,74.580000,454909,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-28,74.750000,76.800000,74.450000,76.750000,76.750000,875274,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-29,78.250000,80.450000,77.570000,79.100000,79.100000,1134467,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-30,79.110000,79.330000,78.365500,78.750000,78.750000,573436,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-07-31,76.970000,77.440000,76.500000,76.720000,76.720000,4645563,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-03,76.720000,77.410000,75.110000,77.110000,77.110000,1768600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-04,77.270000,77.970000,77.230000,77.490000,77.490000,1373725,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-05,77.850000,77.950000,77.120000,77.320000,77.320000,1147719,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-06,77.440000,77.550000,75.210000,76.000000,76.000000,1118649,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-07,75.930000,75.990000,74.635000,75.290000,75.290000,1569404,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-10,76.230000,76.445000,75.820000,76.140000,76.140000,727097,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-11,75.820000,75.830000,74.980000,75.380000,75.380000,700102,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-12,75.100000,75.350000,73.690000,75.040000,75.040000,1410602,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-13,75.150000,75.570000,74.820000,75.000000,75.000000,566823,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-14,74.940000,75.330000,74.420000,75.080000,75.080000,376904,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-17,74.750000,76.230000,74.440000,76.170000,76.170000,649173,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-18,76.160000,76.920000,75.860000,76.030000,76.030000,330663,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-19,75.790000,76.260000,75.340000,75.690000,75.690000,361743,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-20,75.240000,75.890000,74.030000,74.040000,74.040000,551998,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-21,73.320000,74.100000,72.640000,72.940000,72.940000,691731,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-24,69.520000,73.100000,67.470000,70.240000,70.240000,1205190,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-25,71.750000,72.980000,70.620000,71.010000,71.010000,989055,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-26,72.430000,74.290000,71.340000,73.320000,73.320000,594683,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-27,74.070000,74.760000,73.060000,74.200000,74.200000,629738,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-28,74.350000,75.280000,73.690000,75.240000,75.240000,1020418,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-08-31,74.750000,75.000000,73.920000,74.510000,74.510000,1249997,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-01,73.000000,73.370000,71.485000,71.900000,71.900000,707566,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-02,72.510000,74.010000,71.840000,73.840000,73.840000,1014706,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-03,73.750000,74.805000,73.740000,74.340000,74.340000,801769,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-04,73.260000,73.750000,72.340000,72.780000,72.780000,518327,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-08,74.050000,74.560000,73.260000,74.350000,74.350000,666887,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-09,74.570000,75.000000,73.550000,73.990000,73.990000,586637,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-10,73.850000,74.450000,73.440000,74.420000,74.420000,618282,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-11,74.150000,76.330000,73.990000,75.890000,75.890000,826195,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-14,75.780000,75.860000,74.820000,75.610000,75.610000,488001,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-15,75.990000,77.160000,75.400000,76.940000,76.940000,448036,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-16,76.930000,77.630000,76.540000,77.440000,77.440000,643228,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-17,77.430000,78.840000,77.080000,78.440000,78.440000,639901,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-18,77.740000,78.740000,77.370000,77.570000,77.570000,1132472,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-21,78.350000,78.510000,76.238000,76.650000,76.650000,650772,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-22,75.640000,76.130000,75.210000,75.570000,75.570000,446673,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-23,75.890000,76.490000,75.440000,76.010000,76.010000,388403,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-24,75.210000,75.390000,73.960000,75.200000,75.200000,547921,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-25,75.760000,75.842000,72.520000,73.360000,73.360000,893528,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-28,73.180000,73.230000,68.670000,69.060000,69.060000,1060715,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-29,68.770000,69.970000,67.830000,68.860000,68.860000,1023962,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-09-30,69.790000,70.430000,68.750000,69.570000,69.570000,837237,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-01,69.170000,69.980000,68.400000,69.610000,69.610000,847561,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-02,68.650000,71.380000,68.650000,71.330000,71.330000,695177,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-05,71.510000,72.140000,70.180000,70.670000,70.670000,586677,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-06,70.270000,70.590000,66.080000,66.370000,66.370000,1417384,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-07,66.660000,67.970000,65.421000,67.770000,67.770000,1254369,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-08,67.500000,68.120000,66.250000,67.980000,67.980000,756928,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-09,67.810000,70.110000,67.810000,69.830000,69.830000,766132,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-12,69.820000,70.340000,68.900000,70.090000,70.090000,431997,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-13,69.960000,70.995000,69.630800,69.880000,69.880000,615797,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-14,69.600000,70.649900,69.080600,69.230000,69.230000,503224,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-15,68.950000,70.660000,68.581000,70.630000,70.630000,658765,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-16,71.110000,71.880000,70.870000,71.570000,71.570000,1150223,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-19,71.630000,72.680000,70.730000,71.750000,71.750000,380168,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-20,71.810000,72.070000,69.920000,70.180000,70.180000,438425,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-21,70.170000,70.820000,67.520000,68.790000,68.790000,1017199,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-22,69.090000,69.680000,66.760000,67.690000,67.690000,1108207,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-23,68.440000,68.890000,67.450000,68.270000,68.270000,909119,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-26,68.210000,69.490000,68.010000,69.140000,69.140000,538128,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-27,69.160000,69.605000,67.460000,68.760000,68.760000,947601,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-28,68.450000,68.730000,65.200000,66.990000,66.990000,1935651,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-29,66.990000,67.990000,64.151000,64.470000,64.470000,2021132,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-10-30,64.600000,64.740000,63.620000,63.650000,63.650000,1302345,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-02,64.000000,66.170000,63.970000,66.050000,66.050000,1544051,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-03,65.640000,66.410000,65.170000,65.270000,65.270000,1003226,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-04,65.280000,66.280000,64.950000,65.820000,65.820000,1386963,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-05,65.940000,66.320000,65.220000,65.890000,65.890000,911880,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-06,65.850000,66.195000,64.900000,66.090000,66.090000,840491,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-09,66.040000,67.340000,65.704000,67.060000,67.060000,933160,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-10,66.690000,67.620000,66.660000,67.260000,67.260000,582686,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-11,67.300000,68.110000,66.530000,66.580000,66.580000,574589,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-12,66.390000,67.405000,65.400000,66.800000,66.800000,1365716,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-13,66.880000,67.660000,65.710000,66.710000,66.710000,994332,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-16,66.560000,67.490000,66.110000,67.190000,67.190000,690631,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-17,67.260000,68.860000,66.950000,68.580000,68.580000,657932,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-18,68.530000,69.800000,68.160000,69.730000,69.730000,875613,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-19,69.530000,69.910000,68.660000,69.070000,69.070000,1218558,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-20,69.230000,69.670000,68.590000,68.730000,68.730000,786438,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-23,68.770000,69.440000,68.390000,69.240000,69.240000,906566,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-24,68.740000,69.580000,68.525700,69.160000,69.160000,600913,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-25,69.180000,70.020000,68.485000,68.510000,68.510000,706948,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-27,68.810000,69.990000,68.120000,69.260000,69.260000,340031,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-11-30,69.510000,69.560000,67.920000,67.990000,67.990000,775669,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-01,68.340000,69.090000,67.730000,68.940000,68.940000,593683,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-02,68.550000,68.760000,66.587500,66.750000,66.750000,1195708,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-03,67.200000,67.505000,65.760000,65.780000,65.780000,901667,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-04,65.910000,68.070000,65.910000,68.020000,68.020000,848560,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-07,67.740000,68.020000,66.960000,67.410000,67.410000,890203,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-08,66.650000,67.610000,65.890000,67.530000,67.530000,1064439,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-09,67.350000,67.810000,66.110000,66.690000,66.690000,636328,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-10,66.330000,68.050000,65.920000,67.920000,67.920000,752008,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-11,67.220000,67.990000,66.650000,67.350000,67.350000,956717,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-14,67.150000,68.360000,67.030000,68.140000,68.140000,1100636,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-15,68.500000,69.480000,67.981000,68.930000,68.930000,1002392,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-16,69.230000,69.540000,68.030000,68.730000,68.730000,630308,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-17,70.000000,70.740000,69.650000,69.860000,69.860000,1153749,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-18,69.280000,69.899900,69.010000,69.520000,69.520000,1186812,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-21,69.910000,70.240000,69.260000,69.740000,69.740000,649155,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-22,70.300000,70.300000,68.594500,69.290000,69.290000,360408,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-23,69.580000,70.530000,69.010000,70.040000,70.040000,858561,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-24,69.960000,70.160000,69.290000,69.630000,69.630000,170906,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-28,69.580000,69.930000,69.050000,69.580000,69.580000,269107,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-29,70.180000,70.620000,69.810000,70.460000,70.460000,535332,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-30,70.230000,70.520000,69.500000,69.590000,69.590000,372314,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2015-12-31,69.650000,69.650000,68.640000,68.660000,68.660000,675708,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-04,67.860000,67.920000,66.510000,67.040000,67.040000,976683,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-05,66.990000,67.820000,66.800000,67.110000,67.110000,767511,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-06,66.450000,67.690000,66.110000,66.740000,66.740000,1792417,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-07,65.940000,66.480000,65.110000,65.180000,65.180000,790386,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-08,65.400000,65.970000,64.663000,65.100000,65.100000,774787,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-11,65.140000,65.590000,63.950000,64.570000,64.570000,1424584,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-12,64.950000,65.860000,64.160000,65.140000,65.140000,523710,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-13,65.800000,66.210000,63.507000,63.760000,63.760000,851280,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-14,63.740000,64.710000,62.530000,63.960000,63.960000,1393860,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-15,62.300000,63.520000,62.020000,63.340000,63.340000,966727,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-19,63.990000,64.760000,62.840000,63.360000,63.360000,623480,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-20,62.510000,63.820000,60.560000,63.250000,63.250000,933797,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-21,63.430000,64.070000,61.600000,62.470000,62.470000,974031,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-22,63.090000,63.670000,62.340000,63.610000,63.610000,850803,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-25,63.390000,64.000000,62.650000,63.000000,63.000000,925242,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-26,62.970000,63.880000,62.300000,63.500000,63.500000,1286026,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-27,63.320000,63.540000,61.640000,61.930000,61.930000,736890,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-28,62.150000,62.660000,59.890000,60.430000,60.430000,961788,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-01-29,60.750000,61.060000,60.100000,60.830000,60.830000,1248935,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-01,60.860000,61.600000,60.020000,60.530000,60.530000,1381088,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-02,60.220000,60.410000,58.200000,58.280000,58.280000,1229195,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-03,58.520000,59.490000,56.660000,58.550000,58.550000,1324223,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-04,58.230000,59.730000,57.195000,59.530000,59.530000,1672955,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-05,59.530000,59.530000,56.800000,57.500000,57.500000,1773733,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-08,56.870000,57.300000,55.390000,55.910000,55.910000,1076557,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-09,55.110000,57.130000,55.011000,56.700000,56.700000,872052,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-10,56.930000,60.360000,56.600000,58.350000,58.350000,1531053,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-11,59.050000,60.830000,57.720000,59.000000,59.000000,2040002,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-12,60.950000,62.470000,60.060000,60.430000,60.430000,1669203,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-16,61.130000,62.480000,60.230000,61.790000,61.790000,1217980,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-17,62.030000,63.729200,61.980000,63.170000,63.170000,716507,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-18,63.300000,63.730000,62.450000,62.730000,62.730000,648053,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-19,62.310000,63.580000,61.410000,63.430000,63.430000,779089,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-22,64.000000,64.850000,62.245000,62.500000,62.500000,843274,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-23,62.370000,62.940000,61.620000,61.650000,61.650000,656596,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-24,61.160000,62.380000,60.950000,62.100000,62.100000,947102,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-25,62.490000,63.180000,62.080000,62.860000,62.860000,625704,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-26,62.900000,63.540000,62.760000,63.350000,63.350000,563914,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-02-29,63.260000,63.630000,62.485000,62.710000,62.710000,800134,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-01,62.920000,65.450000,62.810100,65.360000,65.360000,1175414,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-02,65.000000,65.480000,64.570000,65.440000,65.440000,836852,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-03,65.290000,65.490000,64.050000,64.670000,64.670000,969376,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-04,64.720000,66.000000,64.270000,65.440000,65.440000,779638,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-07,65.310000,65.460000,64.560000,65.320000,65.320000,607494,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-08,65.090000,66.130000,64.760000,65.650000,65.650000,916848,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-09,65.750000,66.080000,64.785000,65.510000,65.510000,792099,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-10,65.700000,66.220000,65.010000,65.280000,65.280000,551898,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-11,65.890000,67.550000,65.320000,67.400000,67.400000,708589,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-14,67.010000,67.335000,66.050000,66.830000,66.830000,563033,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-15,66.310000,66.480000,64.950000,65.400000,65.400000,1067995,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-16,65.250000,65.890000,64.300000,65.030000,65.030000,648380,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-17,65.000000,65.000000,63.850000,64.650000,64.650000,625493,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-18,64.700000,65.050000,64.230000,64.880000,64.880000,721239,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-21,64.820000,64.960000,64.190000,64.600000,64.600000,1037394,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-22,64.170000,65.750000,64.020000,65.300000,65.300000,707858,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-23,65.380000,65.830000,64.390000,64.540000,64.540000,600538,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-24,64.260000,64.920000,63.660000,64.230000,64.230000,482374,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-28,63.660000,64.490000,63.480000,63.770000,63.770000,690655,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-29,63.960000,65.100000,63.490000,65.070000,65.070000,431025,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-30,65.490000,65.780000,64.290000,64.700000,64.700000,367653,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-03-31,64.610000,65.460000,64.600000,65.100000,65.100000,760034,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-01,64.620000,67.520000,64.480000,67.520000,67.520000,640459,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-04,67.490000,69.410000,67.160100,68.420000,68.420000,904976,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-05,68.000000,69.080000,67.410000,67.690000,67.690000,773084,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-06,67.580000,70.270000,67.580000,70.190000,70.190000,628167,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-07,69.940000,70.700000,69.420000,70.160000,70.160000,887874,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-08,70.550000,71.130000,70.200000,70.830000,70.830000,906434,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-11,71.230000,71.440000,70.050000,70.350000,70.350000,1282891,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-12,70.140000,70.440000,69.170000,69.400000,69.400000,599782,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-13,69.880000,70.142700,69.530000,70.000000,70.000000,651095,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-14,69.990000,70.270000,69.350000,69.670000,69.670000,822267,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-15,69.600000,70.350000,68.920000,70.090000,70.090000,779299,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-18,69.690000,70.030000,69.350000,69.830000,69.830000,546072,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-19,70.090000,70.090000,69.390000,69.740000,69.740000,483060,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-20,69.730000,70.210000,69.360000,69.720000,69.720000,391192,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-21,70.090000,70.685000,69.710000,70.030000,70.030000,683073,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-22,69.880000,70.530000,69.360000,70.040000,70.040000,377038,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-25,70.100000,70.790000,69.620000,70.000000,70.000000,363536,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-26,70.060000,70.260000,68.950000,70.080000,70.080000,918935,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-27,70.020000,70.340000,69.440000,69.820000,69.820000,518978,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-28,69.450000,70.770000,68.480000,69.980000,69.980000,912760,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-04-29,70.000000,70.170000,68.660000,69.070000,69.070000,815551,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-02,69.470000,69.665000,68.130000,69.100000,69.100000,1485734,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-03,64.830000,67.610000,62.950000,67.460000,67.460000,9204548,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-04,65.070000,66.000000,64.340000,65.030000,65.030000,4320105,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-05,65.020000,65.370000,64.320000,64.520000,64.520000,1128565,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-06,64.440000,66.260000,63.940000,65.960000,65.960000,1558272,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-09,65.930000,67.340000,65.840000,67.030000,67.030000,1425157,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-10,67.640000,68.000000,66.900000,67.650000,67.650000,1050457,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-11,67.850000,67.870000,65.850000,65.950000,65.950000,1037538,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-12,65.570000,65.960000,64.670000,65.310000,65.310000,1903764,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-13,65.310000,66.050000,65.030000,65.740000,65.740000,1284374,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-16,65.750000,66.040000,65.370000,65.580000,65.580000,736166,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-17,65.510000,65.780000,65.170000,65.580000,65.580000,1838713,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-18,65.510000,65.898000,65.010000,65.850000,65.850000,1232285,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-19,65.410000,66.000000,64.510000,64.920000,64.920000,1489749,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-20,65.120000,66.840000,64.780000,66.550000,66.550000,1614537,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-23,66.380000,66.840000,65.880000,65.970000,65.970000,1542681,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-24,66.100000,67.030000,65.530000,66.920000,66.920000,1141615,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-25,67.000000,67.100000,66.490000,67.060000,67.060000,1169245,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-26,66.840000,66.895000,66.510000,66.740000,66.740000,863391,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-27,66.580000,67.070000,66.500000,66.700000,66.700000,804165,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-05-31,66.830000,67.950000,66.640000,67.890000,67.890000,1849253,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-01,67.640000,67.990000,67.310000,67.860000,67.860000,1017070,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-02,67.510000,67.950000,67.110000,67.830000,67.830000,1058886,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-03,67.630000,67.740000,66.660000,67.220000,67.220000,561133,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-06,67.460000,67.540000,66.720000,67.210000,67.210000,801352,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-07,67.140000,67.340000,66.760000,67.240000,67.240000,1143870,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-08,66.820000,66.970000,66.630000,66.800000,66.800000,1793150,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-09,66.440000,66.770000,66.160000,66.540000,66.540000,1569163,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-10,65.920000,66.470000,65.320000,65.570000,65.570000,1861286,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-13,65.090000,66.080000,65.090000,65.400000,65.400000,1529941,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-14,65.160000,65.480000,64.820000,65.170000,65.170000,1137420,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-15,65.140000,65.520000,64.980000,65.100000,65.100000,1006483,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-16,65.040000,65.040000,64.600000,64.870000,64.870000,862466,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-17,64.650000,64.990000,63.360000,63.400000,63.400000,1960830,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-20,64.330000,64.569000,63.650000,63.690000,63.690000,1065245,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-21,64.010000,64.100000,63.660000,63.830000,63.830000,967247,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-22,63.700000,64.565000,63.660000,63.920000,63.920000,952092,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-23,64.490000,65.020000,64.030000,65.020000,65.020000,818414,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-24,62.890000,64.200000,62.890000,63.320000,63.320000,1378221,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-27,62.780000,62.830000,61.210000,61.320000,61.320000,1216093,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-28,61.920000,62.520000,61.780000,62.400000,62.400000,1042022,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-29,62.820000,63.710000,62.261400,63.490000,63.490000,1590918,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-06-30,63.520000,65.360000,63.410000,65.320000,65.320000,1664637,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-01,65.140000,66.940000,65.005000,66.860000,66.860000,2059079,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-05,67.180000,67.500000,66.760000,67.230000,67.230000,1748050,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-06,66.880000,68.370000,66.850000,68.310000,68.310000,1851527,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-07,68.400000,68.990000,68.070000,68.990000,68.990000,1311163,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-08,69.220000,71.425000,68.910000,71.410000,71.410000,1997216,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-11,71.760000,71.940000,70.810000,70.820000,70.820000,1216178,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-12,71.420000,71.710000,70.930000,71.060000,71.060000,1760360,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-13,71.420000,71.780000,71.020000,71.060000,71.060000,752052,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-14,71.530000,72.900000,71.330000,72.820000,72.820000,1065888,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-15,72.890000,73.150000,71.620000,71.670000,71.670000,1033053,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-18,71.580000,72.430000,71.580000,72.370000,72.370000,555275,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-19,72.080000,72.560000,71.860000,72.140000,72.140000,1585387,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-20,72.140000,73.320000,72.040000,73.220000,73.220000,1011051,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-21,73.390000,73.660000,72.690000,72.890000,72.890000,1141733,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-22,72.990000,74.240000,72.770000,74.030000,74.030000,923655,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-25,73.890000,74.220000,73.858800,74.080000,74.080000,1137314,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-26,74.230000,75.800000,73.680000,75.450000,75.450000,1324643,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-27,74.200000,75.910000,72.020000,75.000000,75.000000,3662097,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-28,75.550000,78.300000,75.130000,77.920000,77.920000,2169710,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-07-29,76.230000,78.360000,76.100000,77.640000,77.640000,3250255,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-01,77.890000,78.860000,77.750000,78.610000,78.610000,1807270,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-02,77.970000,78.260000,77.120000,77.560000,77.560000,1188694,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-03,77.660000,77.850000,76.860000,77.040000,77.040000,1119688,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-04,77.040000,77.822500,77.040000,77.380000,77.380000,585884,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-05,77.770000,78.310000,77.490000,77.780000,77.780000,606106,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-08,77.270000,77.560000,76.300000,76.560000,76.560000,1042007,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-09,76.780000,77.030000,76.160000,76.480000,76.480000,1036554,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-10,76.500000,76.960000,75.940000,76.810000,76.810000,1117849,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-11,76.980000,77.150000,76.280000,76.750000,76.750000,1111938,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-12,76.640000,76.810000,76.080000,76.400000,76.400000,803775,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-15,76.400000,76.710000,76.190000,76.510000,76.510000,613148,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-16,76.440000,76.630000,75.970000,76.110000,76.110000,501407,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-17,76.120000,76.440000,74.930000,75.300000,75.300000,718486,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-18,74.180000,75.670000,73.850000,75.260000,75.260000,740173,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-19,75.120000,75.130000,74.450000,75.050000,75.050000,760982,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-22,75.090000,76.590000,75.090000,76.590000,76.590000,638026,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-23,76.840000,76.960000,75.950000,76.010000,76.010000,723382,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-24,76.010000,76.230000,75.300000,75.410000,75.410000,1188752,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-25,75.360000,76.110000,75.110000,75.680000,75.680000,748574,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-26,75.640000,75.900000,75.145000,75.690000,75.690000,581588,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-29,75.530000,77.810000,75.030000,77.420000,77.420000,1200543,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-30,77.240000,77.720000,76.890000,77.140000,77.140000,878707,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-08-31,76.940000,77.500000,76.585000,77.300000,77.300000,672274,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-01,77.460000,77.540000,77.055000,77.420000,77.420000,720025,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-02,77.460000,77.780000,76.850000,76.960000,76.960000,359684,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-06,77.020000,77.210000,76.390000,76.540000,76.540000,435411,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-07,76.180000,77.750000,75.670300,77.690000,77.690000,652048,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-08,77.610000,78.010000,77.340000,77.850000,77.850000,662149,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-09,77.060000,77.565000,76.500000,77.070000,77.070000,926843,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-12,76.410000,77.830000,76.350000,77.740000,77.740000,792356,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-13,77.230000,77.860000,76.480000,77.530000,77.530000,1020045,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-14,77.590000,78.560000,77.510000,77.900000,77.900000,1380660,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-15,77.690000,78.170000,77.331400,77.850000,77.850000,954153,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-16,77.650000,77.890000,77.060000,77.310000,77.310000,1251626,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-19,77.600000,77.950000,77.190000,77.380000,77.380000,891636,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-20,77.250000,78.070000,77.230000,77.470000,77.470000,833644,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-21,77.650000,78.155000,77.160000,78.000000,78.000000,455062,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-22,78.390000,78.580000,78.020000,78.130000,78.130000,585794,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-23,77.850000,79.780000,77.300000,79.410000,79.410000,1200846,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-26,79.200000,79.345000,78.420000,78.980000,78.980000,625291,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-27,78.980000,79.730000,78.880000,79.700000,79.700000,465853,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-28,79.850000,79.930000,79.010000,79.570000,79.570000,614784,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-29,79.410000,80.485000,78.921000,79.060000,79.060000,991737,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-09-30,79.180000,81.255000,79.010000,81.060000,81.060000,2438185,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-03,80.870000,81.055000,79.470000,80.200000,80.200000,2112968,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-04,80.200000,80.780000,78.610000,78.790000,78.790000,1564160,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-05,79.380000,81.450000,79.210000,80.540000,80.540000,2266240,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-06,80.640000,80.640000,78.490000,79.270000,79.270000,1940854,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-07,79.070000,79.690000,78.520000,79.460000,79.460000,1348221,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-10,80.040000,80.040000,78.980000,79.810000,79.810000,1225832,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-11,79.300000,79.590000,76.530000,77.230000,77.230000,1100715,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-12,77.100000,77.340000,75.590000,75.890000,75.890000,1162307,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-13,75.560000,76.050000,74.830000,75.700000,75.700000,1341438,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-14,75.510000,76.570000,75.270000,75.340000,75.340000,707026,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-17,75.370000,75.740000,75.090000,75.280000,75.280000,815591,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-18,75.910000,76.690000,75.660000,76.330000,76.330000,911426,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-19,74.990000,76.025000,74.990000,75.210000,75.210000,1158315,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-20,75.000000,75.420000,74.360000,74.420000,74.420000,2417881,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-21,74.290000,74.675000,73.880000,74.020000,74.020000,1849565,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-24,74.400000,74.570000,73.900000,74.540000,74.540000,2339583,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-25,74.320000,74.780000,74.000000,74.430000,74.430000,1624164,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-26,74.460000,74.460000,73.110000,73.120000,73.120000,2196107,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-27,72.420000,72.440000,71.165000,72.100000,72.100000,2295635,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-28,71.810000,72.270000,71.310000,71.770000,71.770000,1451097,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-10-31,72.090000,72.330000,71.550000,71.740000,71.740000,1458200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-01,71.940000,72.440000,71.190000,71.660000,71.660000,1734083,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-02,70.880000,73.990000,70.100000,72.360000,72.360000,2333934,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-03,72.430000,73.620000,72.160000,72.210000,72.210000,1826799,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-04,72.420000,73.220000,72.230000,72.590000,72.590000,1728762,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-07,73.540000,74.700000,73.030000,74.590000,74.590000,2666728,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-08,74.270000,76.305000,74.200000,75.940000,75.940000,2252115,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-09,77.540000,79.510000,76.520000,77.680000,77.680000,2051323,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-10,78.100000,78.465000,77.000000,78.340000,78.340000,1747245,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-11,77.890000,78.669900,76.938200,77.130000,77.130000,1890523,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-14,77.390000,77.950000,76.330000,76.890000,76.890000,1382488,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-15,76.980000,78.635000,76.510100,77.940000,77.940000,1744684,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-16,77.850000,78.050000,77.150000,77.310000,77.310000,1646584,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-17,77.380000,79.710000,77.130000,79.480000,79.480000,1523750,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-18,79.550000,80.020000,78.860000,79.880000,79.880000,1866465,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-21,79.980000,80.440000,79.350000,80.020000,80.020000,1879005,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-22,80.070000,80.550000,79.650000,80.200000,80.200000,1376644,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-23,79.270000,80.120000,77.000000,79.870000,79.870000,2045444,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-25,79.910000,81.060000,79.550000,80.570000,80.570000,549586,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-28,80.630000,80.840000,79.690000,79.820000,79.820000,1516096,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-29,80.020000,81.150000,79.540100,80.930000,80.930000,1737841,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-11-30,81.180000,81.180000,76.500000,76.830000,76.830000,4811134,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-01,75.600000,76.120000,72.730000,73.000000,73.000000,5998122,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-02,72.460000,75.047000,71.900000,74.030000,74.030000,2486636,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-05,74.730000,75.920000,74.570000,75.700000,75.700000,1718248,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-06,75.980000,78.020000,75.480000,77.580000,77.580000,2461138,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-07,77.550000,77.550000,75.830000,76.930000,76.930000,3079688,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-08,77.080000,77.800000,76.270000,77.540000,77.540000,1826940,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-09,77.870000,78.680000,77.870000,78.340000,78.340000,1905434,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-12,78.000000,80.120000,78.000000,79.410000,79.410000,1930766,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-13,80.040000,80.240000,78.930000,79.320000,79.320000,1358386,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-14,79.210000,80.020000,78.210000,79.390000,79.390000,1983217,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-15,79.400000,80.980000,78.950000,80.540000,80.540000,2450771,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-16,78.280000,79.833000,77.850000,77.880000,77.880000,2614697,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-19,78.150000,78.360000,76.400000,76.680000,76.680000,1059065,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-20,77.130000,77.250000,76.340000,76.890000,76.890000,919645,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-21,77.470000,77.630000,75.400000,75.440000,75.440000,1105493,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-22,75.630000,75.920000,74.730000,74.950000,74.950000,1742831,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-23,74.840000,76.270000,74.840000,76.220000,76.220000,623327,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-27,76.330000,76.660000,75.570000,75.850000,75.850000,1177761,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-28,76.240000,76.300000,75.810000,75.960000,75.960000,807768,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-29,75.840000,76.363000,75.730000,75.880000,75.880000,549524,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2016-12-30,75.890000,76.210000,75.510000,76.050000,76.050000,848649,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-03,76.710000,77.420000,76.470000,76.930000,76.930000,1413465,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-04,77.390000,77.590000,76.590000,77.280000,77.280000,1138622,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-05,77.020000,77.530000,76.735000,77.000000,77.000000,651913,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-06,77.060000,78.430000,77.060000,77.820000,77.820000,569329,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-09,78.080000,78.580000,77.810000,77.990000,77.990000,638016,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-10,77.720000,78.340000,77.340000,77.880000,77.880000,1164628,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-11,77.850000,77.950000,75.700000,76.980000,76.980000,1784583,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-12,76.910000,77.510000,76.430000,77.190000,77.190000,1207749,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-13,77.230000,77.960000,76.980000,77.160000,77.160000,654082,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-17,77.150000,77.150000,76.225000,76.790000,76.790000,1015076,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-18,77.100000,77.240000,75.050000,75.590000,75.590000,1983015,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-19,75.490000,76.760000,75.320000,76.070000,76.070000,1523167,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-20,75.790000,76.250000,75.790000,76.100000,76.100000,839379,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-23,75.890000,76.240000,75.115000,75.850000,75.850000,952225,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-24,76.160000,76.180000,74.800000,75.350000,75.350000,1547198,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-25,75.790000,76.110000,75.410000,75.530000,75.530000,964447,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-26,75.500000,76.200000,75.390000,75.540000,75.540000,1026318,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-27,75.740000,76.490000,75.460000,76.360000,76.360000,1027367,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-30,76.110000,76.110000,74.860000,75.350000,75.350000,671884,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-01-31,75.160000,78.530000,74.920000,78.490000,78.490000,1145599,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-01,78.280000,79.020000,77.980000,78.560000,78.560000,1046130,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-02,77.900000,78.250000,76.860000,78.210000,78.210000,666815,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-03,76.530000,78.080000,76.500000,77.620000,77.620000,1033702,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-06,77.810000,78.620000,77.550000,77.750000,77.750000,961140,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-07,78.160000,78.380000,77.540000,77.990000,77.990000,1019382,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-08,77.580000,78.230000,76.580000,78.130000,78.130000,1175957,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-09,78.040000,79.140000,77.960000,78.850000,78.850000,1187051,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-10,79.100000,79.740000,78.670000,79.560000,79.560000,1011381,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-13,79.500000,80.850000,79.450000,80.000000,80.000000,1924529,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-14,79.300000,83.040000,77.600000,82.300000,82.300000,3615777,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-15,81.360000,81.360000,77.560000,77.850000,77.850000,3810487,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-16,77.860000,78.080000,76.260000,76.870000,76.870000,1616593,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-17,77.630000,77.960000,76.030000,76.750000,76.750000,1470641,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-21,76.610000,77.260000,75.940000,76.250000,76.250000,1226137,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-22,76.340000,77.490000,76.060000,77.350000,77.350000,1626389,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-23,77.530000,78.400000,77.370000,78.120000,78.120000,1954538,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-24,78.510000,79.370000,77.385000,77.640000,77.640000,1861848,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-27,77.640000,79.680000,77.000000,79.470000,79.470000,1563227,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-02-28,79.000000,79.000000,77.350000,77.390000,77.390000,1959706,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-01,77.510000,78.210000,76.750000,77.100000,77.100000,2035099,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-02,76.870000,77.150000,76.510000,76.780000,76.780000,1376892,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-03,76.900000,78.230000,76.510000,77.850000,77.850000,1218989,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-06,77.420000,78.570000,77.090000,77.900000,77.900000,1549737,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-07,77.640000,78.060000,77.410000,77.480000,77.480000,1340661,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-08,77.250000,79.820000,76.900000,79.130000,79.130000,1974438,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-09,79.400000,80.010000,79.020000,79.800000,79.800000,1947543,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-10,80.030000,80.970000,79.790000,80.700000,80.700000,2378775,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-13,80.700000,81.100000,80.180000,80.540000,80.540000,2418387,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-14,80.160000,80.710000,79.555000,79.630000,79.630000,2170141,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-15,79.740000,81.230000,79.555000,80.840000,80.840000,1525545,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-16,80.580000,80.820000,79.920000,80.410000,80.410000,1289258,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-17,81.000000,81.990000,80.240000,81.510000,81.510000,3547616,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-20,81.380000,81.500000,79.130000,80.000000,80.000000,1995714,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-21,79.710000,79.970000,77.720000,77.920000,77.920000,1378879,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-22,77.850000,77.990000,76.800000,77.530000,77.530000,1891792,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-23,77.810000,78.590000,77.330000,77.470000,77.470000,1005294,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-24,77.860000,78.500000,77.520000,77.990000,77.990000,699369,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-27,77.740000,78.800000,77.160000,78.700000,78.700000,991094,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-28,78.700000,78.970000,77.975000,78.700000,78.700000,1476611,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-29,78.790000,80.380000,78.560000,80.150000,80.150000,1633984,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-30,79.910000,80.510000,79.750000,79.930000,79.930000,922721,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-03-31,80.370000,80.920000,80.070000,80.530000,80.530000,967380,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-03,80.390000,80.750000,79.690000,80.020000,80.020000,1502924,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-04,79.970000,80.335000,78.540100,78.850000,78.850000,772817,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-05,78.940000,79.260000,78.070000,78.230000,78.230000,1143649,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-06,78.790000,79.360000,78.105000,79.330000,79.330000,998245,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-07,79.200000,79.618500,78.750000,79.190000,79.190000,795640,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-10,78.950000,79.370000,78.680000,78.850000,78.850000,678294,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-11,79.030000,79.340000,78.090000,78.760000,78.760000,675983,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-12,78.990000,79.250000,78.440000,78.670000,78.670000,748410,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-13,78.850000,79.240000,78.300000,78.950000,78.950000,748509,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-17,79.000000,79.520000,78.710000,79.480000,79.480000,514111,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-18,79.160000,80.060000,79.075000,79.990000,79.990000,1224697,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-19,80.500000,81.835000,80.200000,81.300000,81.300000,2451944,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-20,81.500000,82.990000,81.070000,82.880000,82.880000,1848578,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-21,82.910000,83.000000,82.250000,82.250000,82.250000,1781453,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-24,83.000000,83.965000,82.660000,82.750000,82.750000,1109425,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-25,82.590000,83.190000,81.430000,82.650000,82.650000,2069857,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-26,82.660000,83.490000,82.370000,83.020000,83.020000,1394375,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-27,83.300000,84.100000,83.080000,83.680000,83.680000,1065003,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-04-28,83.620000,84.490000,83.570000,84.280000,84.280000,1003008,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-01,84.750000,85.250000,84.200000,84.590000,84.590000,1335543,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-02,84.660000,85.590000,84.170000,85.340000,85.340000,1304535,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-03,85.000000,85.000000,81.620000,82.640000,82.640000,1747407,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-04,83.100000,83.457000,81.820000,82.200000,82.200000,1740677,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-05,82.490000,83.455000,81.960000,83.300000,83.300000,1186171,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-08,82.660000,83.880000,82.310000,83.640000,83.640000,1593446,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-09,83.790000,84.640000,83.590000,84.270000,84.270000,1330697,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-10,84.010000,84.710000,83.310000,83.800000,83.800000,1391502,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-11,83.870000,83.890000,82.950000,83.460000,83.460000,1192682,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-12,83.160000,83.820000,82.860000,82.890000,82.890000,589171,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-15,83.000000,83.910000,82.820000,83.620000,83.620000,817811,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-16,82.100000,83.400000,82.000000,83.190000,83.190000,1106170,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-17,82.810000,83.000000,81.740000,82.220000,82.220000,1078525,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-18,82.290000,83.390000,82.100000,83.090000,83.090000,648078,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-19,83.420000,83.760000,82.940000,83.050000,83.050000,1122290,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-22,83.320000,83.560000,82.830000,83.540000,83.540000,555819,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-23,84.000000,84.000000,83.160000,83.800000,83.800000,767577,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-24,83.980000,84.310000,83.240000,84.220000,84.220000,631807,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-25,84.200000,85.510000,83.899200,84.700000,84.700000,2406964,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-26,84.930000,86.105000,84.600000,86.020000,86.020000,1374708,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-30,85.720000,86.379000,85.230000,85.500000,85.500000,884026,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-05-31,85.640000,86.510000,85.590000,86.440000,86.440000,1502905,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-01,86.810000,87.520000,86.310000,87.130000,87.130000,1148366,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-02,87.500000,88.430000,87.240000,87.930000,87.930000,1081006,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-05,88.220000,88.380000,87.260000,87.290000,87.290000,897928,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-06,87.040000,87.710000,86.540000,87.090000,87.090000,659665,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-07,87.010000,87.900000,86.980000,87.570000,87.570000,758523,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-08,88.000000,88.020000,87.400000,87.800000,87.800000,943424,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-09,87.660000,88.060000,86.095000,86.150000,86.150000,1042610,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-12,86.150000,86.270000,84.300000,85.590000,85.590000,1550443,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-13,85.950000,87.100000,85.830000,86.730000,86.730000,974835,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-14,86.650000,87.170000,85.830000,86.350000,86.350000,565255,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-15,85.970000,86.910000,85.800000,86.630000,86.630000,826061,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-16,86.900000,87.310000,86.380000,87.130000,87.130000,1524616,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-19,87.100000,88.355000,87.100000,87.870000,87.870000,744110,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-20,88.060000,88.700000,87.550000,88.390000,88.390000,897307,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-21,88.800000,90.430000,88.170000,89.780000,89.780000,1291978,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-22,91.670000,91.810000,89.830000,90.880000,90.880000,2837425,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-23,90.770000,91.150000,90.210000,91.080000,91.080000,2552751,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-26,91.180000,91.600000,90.120000,90.180000,90.180000,769439,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-27,90.230000,90.750000,89.370000,89.470000,89.470000,712149,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-28,89.900000,90.795000,89.060000,90.590000,90.590000,715878,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-29,90.750000,90.750000,88.340000,89.420000,89.420000,867560,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-06-30,89.610000,89.760000,89.090000,89.500000,89.500000,718769,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-03,89.600000,89.600000,88.150000,88.230000,88.230000,532132,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-05,88.480000,89.360000,88.160000,89.160000,89.160000,634488,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-06,88.680000,88.680000,87.641000,87.860000,87.860000,723672,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-07,88.950000,89.940000,88.000000,88.850000,88.850000,954521,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-10,88.980000,89.050000,88.050000,88.270000,88.270000,598225,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-11,88.270000,88.690000,87.800000,88.120000,88.120000,606687,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-12,88.680000,89.410000,88.380000,88.910000,88.910000,551275,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-13,89.230000,89.720000,88.390000,89.220000,89.220000,634376,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-14,89.260000,89.570000,88.830000,89.380000,89.380000,464484,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-17,89.880000,90.810000,89.610000,90.080000,90.080000,958313,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-18,89.940000,90.170000,89.375000,90.070000,90.070000,641887,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-19,90.390000,91.190000,90.250000,90.960000,90.960000,649618,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-20,90.890000,90.940000,89.890000,90.300000,90.300000,760089,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-21,90.400000,91.480000,90.400000,91.150000,91.150000,753238,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-24,91.740000,91.890000,91.060000,91.720000,91.720000,915898,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-25,91.700000,91.945000,90.070000,90.520000,90.520000,860541,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-26,90.820000,91.880000,90.770000,91.700000,91.700000,840477,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-27,91.960000,92.540000,91.390000,91.590000,91.590000,967188,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-28,91.160000,91.880000,90.000000,90.650000,90.650000,1015413,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-07-31,90.840000,91.610000,90.510000,90.550000,90.550000,890731,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-01,90.620000,91.340000,90.200000,91.290000,91.290000,1039447,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-02,91.810000,92.535000,90.900000,91.620000,91.620000,1451161,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-03,90.250000,93.420000,90.250000,91.100000,91.100000,1584430,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-04,92.650000,93.530000,90.030000,90.420000,90.420000,1263883,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-07,90.620000,91.320000,89.950000,91.190000,91.190000,1055896,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-08,91.170000,91.255000,90.090000,90.670000,90.670000,980286,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-09,90.060000,90.910000,90.000000,90.100000,90.100000,1320509,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-10,89.880000,90.330000,87.450000,87.570000,87.570000,1364169,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-11,87.700000,89.210000,87.680000,88.910000,88.910000,1006508,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-14,89.430000,90.550000,89.255000,89.990000,89.990000,1208324,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-15,90.040000,92.200000,89.760000,91.530000,91.530000,1679376,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-16,91.670000,93.050000,91.580000,92.590000,92.590000,1271411,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-17,92.210000,93.130000,91.670000,91.700000,91.700000,1255161,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-18,91.530000,92.220000,90.560000,91.550000,91.550000,1191690,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-21,91.550000,93.080000,91.550000,93.080000,93.080000,1154399,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-22,93.300000,94.830000,93.190000,94.730000,94.730000,1055703,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-23,94.300000,94.930000,93.760000,94.110000,94.110000,676440,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-24,94.550000,95.450000,94.180000,95.110000,95.110000,1461141,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-25,98.350000,99.950000,97.875000,98.820000,98.820000,9833611,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-28,97.460000,98.740000,95.070000,95.550000,95.550000,34428151,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-29,95.410000,97.330000,95.250000,96.000000,96.000000,3382304,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-30,95.870000,97.070000,95.440000,95.790000,95.790000,1909190,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-08-31,95.960000,96.410000,94.780000,96.030000,96.030000,1835676,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-01,96.050000,96.730000,95.290000,95.680000,95.680000,1270031,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-05,95.500000,97.010000,95.490000,96.950000,96.950000,2303308,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-06,97.590000,97.590000,95.920000,96.250000,96.250000,1565566,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-07,96.690000,97.370000,95.850000,96.740000,96.740000,1061914,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-08,96.480000,97.140000,96.240000,97.000000,97.000000,834955,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-11,97.500000,97.511700,96.300000,96.940000,96.940000,1334263,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-12,96.880000,97.595000,96.370000,97.520000,97.520000,888647,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-13,97.570000,97.570000,96.320000,96.570000,96.570000,1002617,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-14,95.950000,96.191800,95.150000,95.450000,95.450000,1326993,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-15,94.940000,95.040000,93.850000,94.470000,94.470000,5759583,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-18,94.520000,95.350000,94.360000,95.070000,95.070000,2055918,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-19,95.500000,95.530000,94.570000,95.000000,95.000000,1086208,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-20,94.930000,95.180000,94.150000,94.640000,94.640000,1510201,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-21,94.410000,94.530000,93.890000,94.220000,94.220000,921266,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-22,93.840000,94.700000,93.790000,94.700000,94.700000,1149074,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-25,94.560000,94.970000,94.210000,94.950000,94.950000,1133175,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-26,94.880000,95.270000,93.980000,94.080000,94.080000,1617769,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-27,94.220000,95.550000,94.100000,95.210000,95.210000,1892090,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-28,95.000000,95.180000,94.420000,94.960000,94.960000,755067,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-09-29,95.000000,95.240000,94.430000,95.070000,95.070000,1027172,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-02,95.170000,95.490000,94.280000,95.000000,95.000000,1226638,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-03,95.000000,95.300000,94.500000,95.100000,95.100000,967155,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-04,94.950000,95.380000,94.760000,95.250000,95.250000,854913,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-05,95.480000,95.785000,94.950000,95.600000,95.600000,1257246,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-06,95.710000,95.850000,95.410000,95.700000,95.700000,1546728,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-09,95.600000,95.980000,95.270000,95.790000,95.790000,727909,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-10,95.900000,96.340000,95.240000,96.200000,96.200000,1605543,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-11,96.490000,97.940000,96.429200,97.760000,97.760000,2483153,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-12,97.630000,98.720000,97.605000,98.450000,98.450000,1055883,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-13,98.500000,100.000000,98.020000,99.850000,99.850000,1584104,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-16,100.100000,100.565000,99.030000,99.330000,99.330000,1198088,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-17,99.260000,99.920000,99.065000,99.670000,99.670000,1137575,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-18,99.860000,101.870000,99.670000,100.930000,100.930000,1689442,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-19,100.100000,102.090000,100.100000,101.820000,101.820000,1472363,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-20,102.240000,103.380000,101.870000,103.030000,103.030000,1920105,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-23,103.180000,103.280000,102.150000,102.160000,102.160000,1484220,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-24,102.520000,102.750000,101.560000,102.330000,102.330000,1220216,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-25,101.890000,102.980000,101.350000,101.430000,101.430000,1300186,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-26,101.590000,106.650000,100.000000,105.500000,105.500000,3206995,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-27,107.060000,108.430000,105.310000,107.660000,107.660000,2775287,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-30,107.460000,108.630000,106.690000,107.170000,107.170000,1021326,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-10-31,107.140000,108.810000,107.140000,108.100000,108.100000,1389366,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-01,108.250000,109.000000,107.590000,108.430000,108.430000,813717,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-02,108.400000,108.520000,107.080000,107.300000,107.300000,963526,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-03,107.120000,108.380000,106.480000,108.020000,108.020000,1059100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-06,107.000000,109.290000,106.885000,108.560000,108.560000,954313,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-07,108.890000,110.670000,108.130000,108.190000,108.190000,1162706,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-08,108.520000,108.820000,103.820000,104.720000,104.720000,3088739,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-09,103.550000,103.770000,101.500000,103.510000,103.510000,2696460,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-10,103.700000,104.610000,103.570000,104.050000,104.050000,1138189,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-13,101.980000,103.870000,101.180000,102.910000,102.910000,1532547,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-14,102.580000,103.660000,101.620000,103.480000,103.480000,1299753,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-15,102.670000,104.380000,100.900000,103.840000,103.840000,585527,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-16,104.550000,104.840000,103.440000,104.440000,104.440000,934752,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-17,103.730000,105.540000,103.730000,104.460000,104.460000,690163,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-20,104.440000,104.990000,103.870000,103.900000,103.900000,1126726,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-21,103.880000,105.000000,103.370000,104.360000,104.360000,1210517,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-22,104.210000,106.000000,103.920000,103.950000,103.950000,758603,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-24,103.950000,105.560000,103.950000,104.270000,104.270000,483627,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-27,104.270000,104.720000,102.280000,102.550000,102.550000,1129982,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-28,102.250000,102.800000,101.590000,101.730000,101.730000,6121725,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-29,101.730000,102.450000,100.720000,101.310000,101.310000,1711510,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-11-30,101.900000,103.170000,101.830000,102.010000,102.010000,2777482,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-01,102.430000,102.770000,100.500000,102.270000,102.270000,1668173,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-04,102.640000,103.260000,101.200000,101.270000,101.270000,1364375,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-05,101.150000,102.550000,100.871000,101.000000,101.000000,1012132,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-06,100.930000,101.960000,100.410000,101.010000,101.010000,919854,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-07,101.100000,101.500000,100.830000,100.920000,100.920000,1057768,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-08,101.060000,101.860000,100.650000,101.350000,101.350000,705739,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-11,101.930000,102.220000,100.940000,101.680000,101.680000,1008121,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-12,101.680000,101.830000,100.860000,101.650000,101.650000,784388,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-13,101.830000,103.280000,101.300000,102.220000,102.220000,1211197,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-14,102.605000,103.140000,101.460000,101.470000,101.470000,941647,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-15,101.390000,102.220000,101.270000,102.060000,102.060000,2334663,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-18,102.770000,103.100000,101.760000,102.480000,102.480000,1000150,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-19,102.560000,102.858700,101.110000,101.260000,101.260000,1257915,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-20,101.530000,101.600000,100.280000,100.320000,100.320000,1468751,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-21,100.220000,100.795000,99.880000,100.140000,100.140000,1279939,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-22,99.880000,100.015000,98.505000,99.380000,99.380000,960488,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-26,99.560000,99.729900,98.300000,98.350000,98.350000,716515,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-27,98.290000,99.350000,98.011000,98.540000,98.540000,1297653,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-28,98.880000,98.880000,97.450000,98.310000,98.310000,1244955,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2017-12-29,98.680000,98.860000,97.870100,97.900000,97.900000,838394,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-02,98.520000,100.470000,97.570000,99.760000,99.760000,1348932,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-03,99.760000,100.160000,99.080000,99.520000,99.520000,738260,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-04,99.450000,100.120000,97.150000,97.280000,97.280000,1795633,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-05,97.440000,98.830000,97.340000,98.560000,98.560000,1376490,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-08,98.480000,98.790000,98.130000,98.600000,98.600000,830363,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-09,98.960000,99.000000,98.050000,98.540000,98.540000,1159777,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-10,98.370000,99.000000,97.200000,98.870000,98.870000,775688,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-11,99.270000,100.060000,98.450000,99.860000,99.860000,1462166,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-12,99.930000,100.680000,99.460000,100.040000,100.040000,742041,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-16,100.430000,101.010000,99.850000,99.930000,99.930000,957507,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-17,100.500000,100.580000,99.565100,100.220000,100.220000,975107,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-18,100.370000,100.740000,99.740000,99.920000,99.920000,773237,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-19,100.340000,103.045100,100.340000,103.000000,103.000000,1315872,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-22,102.760000,104.030000,102.480000,102.840000,102.840000,1661433,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-23,102.960000,104.070000,102.600000,103.210000,103.210000,930052,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-24,103.210000,103.840000,103.110000,103.500000,103.500000,703373,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-25,103.500000,105.100000,103.500000,104.580000,104.580000,814998,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-26,105.000000,106.130000,104.680000,106.010000,106.010000,1763264,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-29,105.040000,106.330000,104.341000,105.580000,105.580000,858252,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-30,105.300000,106.215000,103.640000,104.370000,104.370000,774671,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-01-31,104.590000,104.970000,101.860000,102.190000,102.190000,1382801,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-01,102.120000,104.180000,101.380000,104.120000,104.120000,1083753,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-02,103.330000,103.330000,100.500000,100.540000,100.540000,825647,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-05,100.320000,100.990000,95.960000,96.750000,96.750000,1291530,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-06,95.210000,98.470000,93.098900,98.060000,98.060000,1621334,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-07,98.190000,100.250000,98.160000,98.210000,98.210000,904892,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-08,98.290000,98.910000,95.220000,95.230000,95.230000,941590,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-09,96.260000,96.880000,94.120000,96.050000,96.050000,1183251,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-12,96.900000,99.439000,95.950000,98.630000,98.630000,1257163,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-13,98.100000,101.230000,97.770000,100.060000,100.060000,1313741,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-14,100.980000,108.380000,100.000000,104.680000,104.680000,2270776,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-15,105.510000,106.270000,99.780000,101.570000,101.570000,1869338,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-16,101.390000,102.500000,101.160000,101.720000,101.720000,1266937,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-20,101.580000,102.070000,99.780000,100.260000,100.260000,1300382,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-21,100.640000,101.490000,99.730000,99.760000,99.760000,1364059,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-22,100.020000,100.750000,97.820000,98.380000,98.380000,1248036,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-23,98.870000,99.925000,98.210000,99.780000,99.780000,1397831,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-26,100.000000,100.750000,98.510000,99.970000,99.970000,1655956,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-27,99.970000,100.900000,98.710000,99.570000,99.570000,1146329,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-02-28,99.860000,100.220000,98.290000,98.330000,98.330000,1764197,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-01,98.430000,98.870000,96.725000,97.200000,97.200000,1237524,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-02,96.940000,99.520000,96.240000,98.170000,98.170000,989902,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-05,98.030000,100.150000,96.940000,99.690000,99.690000,833141,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-06,99.920000,100.760000,99.630000,100.660000,100.660000,620596,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-07,100.740000,102.330000,100.330000,101.930000,101.930000,773903,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-08,102.270000,103.750000,101.770000,103.250000,103.250000,1033460,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-09,103.780000,105.660000,102.980000,105.600000,105.600000,916357,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-12,105.960000,106.810000,105.450000,105.930000,105.930000,984527,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-13,106.120000,106.740000,105.100000,105.680000,105.680000,760841,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-14,106.080000,106.320000,104.370000,104.840000,104.840000,1109950,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-15,105.320000,106.500000,105.005000,105.340000,105.340000,716626,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-16,105.270000,106.000000,104.928300,105.690000,105.690000,830959,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-19,105.460000,105.500000,103.950000,104.760000,104.760000,577159,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-20,104.570000,105.090000,104.080000,104.810000,104.810000,562772,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-21,105.000000,105.680000,104.090000,104.110000,104.110000,676297,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-22,103.270000,104.180000,101.590000,101.880000,101.880000,670677,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-23,102.060000,102.490000,99.560000,99.720000,99.720000,843639,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-26,101.050000,101.800000,99.040000,101.660000,101.660000,764218,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-27,102.190000,102.190000,99.460000,100.060000,100.060000,935535,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-28,100.090000,100.090000,97.590000,98.620000,98.620000,1203437,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-03-29,99.020000,99.040000,96.460000,98.110000,98.110000,2042889,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-02,98.180000,99.565000,94.760000,95.700000,95.700000,1063671,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-03,95.840000,96.490000,94.670000,95.720000,95.720000,1525027,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-04,95.580000,97.030000,94.650000,96.830000,96.830000,630257,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-05,97.600000,97.600000,96.170000,97.000000,97.000000,845210,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-06,96.540000,96.960000,94.260000,94.850000,94.850000,964842,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-09,94.850000,96.700000,94.550000,95.480000,95.480000,542392,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-10,96.310000,97.510000,95.435000,96.610000,96.610000,671166,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-11,95.910000,96.700000,95.750000,95.980000,95.980000,865412,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-12,96.240000,97.000000,96.090000,96.120000,96.120000,561074,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-13,98.500000,98.500000,96.850000,97.710000,97.710000,894577,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-16,98.340000,98.340000,97.420000,98.040000,98.040000,710066,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-17,98.570000,99.060000,97.800000,98.800000,98.800000,662979,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-18,98.880000,100.300000,98.810000,99.250000,99.250000,844629,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-19,99.210000,100.100000,97.530000,98.070000,98.070000,569667,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-20,98.380000,98.450000,97.020000,97.270000,97.270000,603898,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-23,97.440000,99.080000,97.115000,98.010000,98.010000,1104917,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-24,97.840000,98.345000,95.905000,96.740000,96.740000,864890,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-25,96.560000,96.990000,95.095000,96.490000,96.490000,548727,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-26,96.920000,97.150000,96.150000,96.500000,96.500000,1037132,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-27,96.400000,97.000000,95.860000,96.450000,96.450000,936905,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-04-30,96.800000,97.290000,95.750000,95.760000,95.760000,1097680,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-01,95.640000,98.810000,95.530000,97.990000,97.990000,1392842,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-02,97.610000,99.240000,95.560000,96.910000,96.910000,1581203,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-03,96.850000,97.720000,95.745000,97.300000,97.300000,950175,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-04,96.430000,99.390000,96.360000,99.020000,99.020000,951784,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-07,99.220000,99.680000,97.940000,98.170000,98.170000,1037108,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-08,97.650000,99.040000,97.650000,98.250000,98.250000,708904,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-09,98.530000,99.420000,97.660000,99.390000,99.390000,579677,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-10,99.600000,100.960000,98.920000,100.930000,100.930000,794107,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-11,100.550000,103.250000,100.550000,103.020000,103.020000,905085,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-14,103.110000,103.880000,102.430400,102.890000,102.890000,784048,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-15,102.460000,103.970000,101.630000,102.100000,102.100000,1220904,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-16,101.350000,101.780000,91.570100,99.130000,99.130000,10720361,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-17,99.350000,99.350000,97.400000,97.830000,97.830000,2271330,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-18,99.840000,102.070000,99.690000,101.630000,101.630000,4200347,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-21,101.710000,103.370000,101.420000,102.210000,102.210000,1434938,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-22,102.150000,103.050000,101.640000,102.630000,102.630000,1387080,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-23,101.810000,103.150000,101.540000,102.440000,102.440000,1882580,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-24,102.660000,103.290000,101.650000,101.760000,101.760000,1223542,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-25,101.760000,101.990000,100.090000,100.500000,100.500000,1128663,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-29,100.180000,100.430000,98.250000,99.180000,99.180000,1240565,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-30,99.880000,100.870000,99.744700,100.480000,100.480000,968866,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-05-31,100.580000,100.580000,98.570000,98.930000,98.930000,1818753,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-01,99.460000,100.580000,98.600000,100.490000,100.490000,669591,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-04,100.410000,101.280000,99.840000,101.240000,101.240000,750317,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-05,101.360000,101.920000,100.440000,101.880000,101.880000,756797,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-06,101.800000,103.860000,101.489600,103.690000,103.690000,722385,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-07,103.800000,103.950000,102.480000,103.170000,103.170000,569757,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-08,103.280000,104.910000,103.280000,104.600000,104.600000,1090887,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-11,104.530000,104.670000,103.830000,104.170000,104.170000,636373,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-12,104.160000,105.230000,104.160000,104.950000,104.950000,705596,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-13,103.000000,103.620000,102.290000,103.360000,103.360000,4309684,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-14,103.770000,103.900000,102.730000,103.160000,103.160000,1751558,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-15,102.630000,103.400000,101.810000,103.280000,103.280000,2575702,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-18,104.000000,105.450000,103.490000,104.880000,104.880000,3648112,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-19,104.500000,106.000000,104.306200,105.950000,105.950000,2742743,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-20,105.830000,106.990000,105.540000,105.610000,105.610000,1278369,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-21,105.950000,105.950000,104.600000,104.730000,104.730000,984543,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-22,105.220000,105.220000,103.240000,103.840000,103.840000,5843702,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-25,103.700000,103.700000,100.720000,100.810000,100.810000,1757966,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-26,100.960000,101.240000,99.970000,100.700000,100.700000,1264867,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-27,100.890000,101.210000,98.570000,98.700000,98.700000,1139907,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-28,98.340000,99.305000,97.645000,99.190000,99.190000,1734850,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-06-29,99.760000,100.590000,99.430000,99.820000,99.820000,1833514,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-02,99.420000,99.450000,98.170000,99.300000,99.300000,1634590,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-03,101.000000,101.400000,100.000000,100.610000,100.610000,928030,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-05,101.440000,101.440000,99.650000,100.400000,100.400000,963120,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-06,100.630000,101.880000,100.450100,101.710000,101.710000,986007,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-09,102.110000,102.960000,101.940000,102.750000,102.750000,1053936,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-10,103.230000,103.990000,103.070000,103.920000,103.920000,888042,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-11,103.350000,104.547900,103.250000,104.210000,104.210000,1242941,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-12,105.040000,106.970000,104.750000,106.900000,106.900000,1188634,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-13,106.740000,107.710000,106.040000,107.270000,107.270000,1259026,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-16,107.730000,108.050000,107.070000,107.690000,107.690000,1482803,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-17,107.520000,109.240000,107.380000,109.000000,109.000000,1029543,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-18,108.830000,109.680000,108.390000,109.680000,109.680000,1384234,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-19,109.490000,110.790000,109.180000,110.250000,110.250000,1282018,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-20,110.080000,111.170000,110.030000,111.110000,111.110000,1364024,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-23,111.360000,112.150000,111.120000,111.370000,111.370000,1925833,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-24,113.170000,120.910000,113.170000,118.380000,118.380000,3575806,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-25,119.550000,125.350000,118.970000,125.240000,125.240000,3040326,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-26,124.600000,124.600000,120.920000,122.030000,122.030000,2457711,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-27,121.880000,121.890000,119.640000,120.450000,120.450000,812204,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-30,120.730000,121.820000,120.120000,120.920000,120.920000,1109052,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-07-31,121.480000,123.170000,121.250000,121.940000,121.940000,1221093,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-01,122.200000,122.960000,121.780000,122.060000,122.060000,861203,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-02,121.930000,124.675000,121.930000,124.360000,124.360000,1321038,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-03,124.430000,124.430000,122.505000,123.140000,123.140000,742491,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-06,123.070000,123.320000,121.740000,122.160000,122.160000,1299873,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-07,122.600000,123.250000,121.959800,122.860000,122.860000,650173,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-08,122.820000,123.520000,121.910000,121.980000,121.980000,437445,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-09,122.200000,122.960000,121.560000,121.700000,121.700000,588918,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-10,120.790000,122.030000,120.420000,121.150000,121.150000,485715,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-13,121.620000,122.445000,120.490000,120.800000,120.800000,591422,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-14,120.930000,121.930000,120.100000,121.200000,121.200000,837897,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-15,120.890000,120.900000,119.585100,120.200000,120.200000,1111266,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-16,120.470000,121.990000,119.870000,121.030000,121.030000,491273,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-17,121.000000,121.500000,119.740000,120.280000,120.280000,833892,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-20,120.900000,121.300000,119.530000,120.300000,120.300000,1405354,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-21,120.760000,124.000000,120.760000,122.520000,122.520000,1899973,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-22,122.280000,124.100000,121.690000,123.860000,123.860000,1122108,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-23,124.130000,125.450000,123.810000,124.390000,124.390000,884920,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-24,124.500000,126.329500,124.480000,125.420000,125.420000,1011349,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-27,126.440000,126.939900,125.200000,126.420000,126.420000,852731,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-28,126.250000,126.950000,126.080000,126.560000,126.560000,466097,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-29,126.560000,126.850000,126.125000,126.190000,126.190000,682677,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-30,126.340000,126.450000,125.310000,125.910000,125.910000,458967,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-08-31,125.890000,127.280000,125.890000,127.090000,127.090000,736695,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-04,126.900000,128.100000,125.960000,128.040000,128.040000,810676,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-05,128.030000,128.400000,125.500000,125.950000,125.950000,1301749,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-06,126.060000,127.045000,125.320000,126.880000,126.880000,1066201,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-07,126.320000,127.720000,126.240000,127.020000,127.020000,1014546,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-10,127.720000,128.210000,126.750000,127.920000,127.920000,529208,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-11,127.600000,127.600000,123.360000,124.990000,124.990000,2235883,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-12,124.650000,125.340000,122.280000,125.150000,125.150000,1268309,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-13,125.830000,127.320000,124.485000,126.510000,126.510000,1167710,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-14,126.310000,127.980000,125.740000,126.590000,126.590000,560207,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-17,126.400000,126.400000,124.920000,125.070000,125.070000,1272732,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-18,125.220000,127.660000,124.640000,125.550000,125.550000,1513444,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-19,125.660000,126.000000,124.940000,125.230000,125.230000,747642,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-20,125.760000,127.350000,125.320000,127.170000,127.170000,1254273,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-21,127.710000,128.370000,126.380000,127.580000,127.580000,2623377,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-24,127.240000,128.730000,126.900000,128.560000,128.560000,807059,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-25,129.000000,130.430000,128.590000,129.820000,129.820000,1150648,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-26,130.470000,131.420000,129.840000,129.930000,129.930000,1387085,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-27,130.000000,130.870000,129.510000,130.770000,130.770000,826893,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-09-28,130.570000,131.710000,129.480000,129.740000,129.740000,1106579,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-01,130.280000,130.520000,128.810000,130.070000,130.070000,1538667,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-02,130.240000,130.860000,129.080000,130.200000,130.200000,967879,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-03,130.770000,132.235000,129.670000,130.350000,130.350000,993725,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-04,129.730000,130.197000,126.730000,127.000000,127.000000,939631,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-05,126.890000,129.040000,126.570000,127.790000,127.790000,1072643,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-08,127.880000,127.880000,125.430000,126.440000,126.440000,821921,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-09,126.340000,128.435000,125.850000,127.380000,127.380000,945753,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-10,127.310000,127.760000,122.600000,122.810000,122.810000,879071,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-11,122.570000,124.920000,121.000000,122.580000,122.580000,1626682,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-12,124.340000,126.190000,123.500000,124.790000,124.790000,817784,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-15,124.480000,125.380000,123.695000,124.260000,124.260000,675931,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-16,125.170000,129.740000,125.170000,129.610000,129.610000,930371,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-17,129.190000,129.800000,128.120000,129.380000,129.380000,699914,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-18,129.480000,129.850000,126.760000,128.420000,128.420000,807486,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-19,128.750000,130.220000,126.500000,126.890000,126.890000,1574001,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-22,130.260000,135.480000,124.430000,126.450000,126.450000,2807000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-23,124.470000,124.470000,115.330000,122.480000,122.480000,2968120,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-24,122.250000,123.710000,115.002100,115.240000,115.240000,1954565,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-25,116.460000,121.160000,115.850100,119.920000,119.920000,1809372,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-26,118.500000,121.050000,117.590000,120.190000,120.190000,2385772,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-29,119.680000,123.560000,118.610000,120.810000,120.810000,1969361,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-30,121.260000,122.360000,118.540000,119.830000,119.830000,1433785,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-10-31,120.890000,124.860000,120.890000,122.930000,122.930000,1391750,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-01,123.330000,123.775000,121.450000,122.240000,122.240000,1050608,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-02,122.900000,123.550000,120.419000,121.710000,121.710000,1135796,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-05,122.310000,122.310000,120.800000,121.670000,121.670000,1847735,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-06,121.780000,122.880000,121.305000,122.370000,122.370000,858873,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-07,123.770000,126.770000,123.450000,126.620000,126.620000,943739,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-08,125.910000,126.830000,125.290000,125.690000,125.690000,780064,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-09,125.210000,126.030000,122.765000,124.170000,124.170000,656486,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-12,123.670000,123.905000,120.270000,121.120000,121.120000,712463,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-13,121.490000,122.810000,119.535000,119.660000,119.660000,1230010,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-14,120.370000,122.570000,117.220000,117.410000,117.410000,1433521,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-15,117.200000,119.400000,115.390000,119.130000,119.130000,1325065,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-16,118.580000,120.460000,117.690000,119.390000,119.390000,1730728,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-19,119.560000,120.270000,114.860000,115.440000,115.440000,1407070,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-20,114.330000,117.060000,113.120000,115.850000,115.850000,1266194,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-21,116.610000,118.130000,116.050000,116.210000,116.210000,1174620,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-23,115.670000,119.010000,115.150000,117.730000,117.730000,286369,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-26,118.780000,119.920000,118.140000,119.580000,119.580000,1010093,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-27,118.880000,120.300000,118.490000,120.070000,120.070000,1164870,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-28,120.410000,124.210000,120.030000,124.180000,124.180000,1510970,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-29,123.650000,126.120000,123.650000,124.950000,124.950000,1029785,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-11-30,123.640000,125.250000,121.820000,125.070000,125.070000,2966367,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-03,128.640000,129.010000,126.845000,127.380000,127.380000,2208841,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-04,127.190000,127.890000,123.040000,123.150000,123.150000,2852224,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-06,121.350000,121.860000,118.350000,121.850000,121.850000,1716513,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-07,121.040000,121.810000,117.045000,117.980000,117.980000,1535153,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-10,118.600000,119.340000,115.730000,119.120000,119.120000,1402755,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-11,120.110000,122.340000,120.110000,121.500000,121.500000,1875361,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-12,122.520000,125.030000,122.100000,122.340000,122.340000,1517874,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-13,122.730000,123.820000,119.610000,121.500000,121.500000,978580,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-14,120.710000,120.710000,117.600000,118.020000,118.020000,1429297,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-17,117.500000,118.040000,114.915000,115.660000,115.660000,2106081,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-18,116.240000,116.990000,114.060000,115.460000,115.460000,1988900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-19,115.280000,116.570000,111.620000,113.790000,113.790000,1714459,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-20,113.080000,114.000000,109.520000,110.200000,110.200000,2029108,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-21,110.130000,111.210000,107.590000,108.220000,108.220000,2710717,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-24,107.420000,107.800000,104.900000,105.700000,105.700000,876254,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-26,105.780000,111.450000,105.520000,111.190000,111.190000,1253032,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-27,109.320000,112.440000,107.950000,112.380000,112.380000,997730,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-28,112.800000,115.280000,111.950000,113.910000,113.910000,1280514,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2018-12-31,114.610000,116.190000,114.350000,116.170000,116.170000,991381,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-02,114.410000,115.760000,112.380000,114.310000,114.310000,1155698,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-03,112.750000,113.170000,107.790000,109.960000,109.960000,2178879,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-04,111.210000,115.990000,110.525000,115.070000,115.070000,1402417,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-07,115.260000,118.635000,114.750000,117.200000,117.200000,1170756,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-08,118.290000,119.700000,116.960000,119.630000,119.630000,1286786,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-09,120.000000,122.550000,120.000000,122.160000,122.160000,1609272,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-10,121.570000,123.430000,120.300000,123.360000,123.360000,1032394,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-11,123.420000,123.420000,121.110000,122.810000,122.810000,1136003,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-14,121.720000,122.150000,121.170000,121.490000,121.490000,919611,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-15,121.570000,122.970000,121.210000,122.880000,122.880000,1332471,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-16,123.590000,125.820000,123.510000,124.740000,124.740000,1491445,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-17,124.140000,124.740000,122.550000,124.090000,124.090000,1268486,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-18,126.410000,127.610000,124.905000,127.190000,127.190000,2140093,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-22,126.150000,126.729900,124.450000,124.860000,124.860000,1314263,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-23,125.620000,126.540000,123.700000,126.130000,126.130000,989721,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-24,125.840000,125.980000,123.905000,125.110000,125.110000,1363839,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-25,125.150000,126.750000,125.150000,125.980000,125.980000,1004430,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-28,124.710000,125.150000,123.570000,124.690000,124.690000,888152,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-29,124.900000,125.340000,123.865700,124.890000,124.890000,659823,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-30,124.720000,127.990000,124.550000,127.560000,127.560000,530481,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-01-31,127.190000,129.090000,126.500000,129.010000,129.010000,941529,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-01,129.130000,130.000000,128.160000,129.560000,129.560000,1076824,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-04,129.370000,129.960000,128.470000,129.020000,129.020000,1158077,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-05,128.930000,130.640000,128.930000,130.090000,130.090000,952531,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-06,129.930000,131.090000,129.500000,130.660000,130.660000,638228,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-07,139.650000,139.650000,128.490000,129.650000,129.650000,919495,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-08,128.650000,129.220000,128.230000,128.810000,128.810000,935367,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-11,128.700000,129.970000,128.700000,129.100000,129.100000,794893,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-12,129.780000,131.830000,128.900000,131.660000,131.660000,1647057,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-13,132.290000,132.370000,130.175000,131.820000,131.820000,1245536,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-14,135.000000,143.420000,135.000000,141.130000,141.130000,3219613,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-15,142.810000,143.360000,140.170000,141.850000,141.850000,1754495,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-19,141.320000,142.670000,140.670000,141.490000,141.490000,1080264,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-20,141.680000,141.680000,139.900000,141.190000,141.190000,1058400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-21,141.190000,142.850000,140.830000,142.020000,142.020000,1550041,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-22,141.700000,143.080000,141.150000,142.460000,142.460000,1050594,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-25,143.290000,143.660000,141.670000,141.770000,141.770000,1362441,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-26,141.630000,142.140000,140.380000,140.990000,140.990000,1351914,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-27,140.500000,142.085000,140.250000,141.640000,141.640000,1051395,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-02-28,141.300000,141.390000,140.050000,140.100000,140.100000,1263275,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-01,140.900000,143.920000,140.900000,143.350000,143.350000,1375615,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-04,143.640000,144.766000,139.800000,141.490000,141.490000,973865,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-05,141.690000,143.450000,141.290000,141.490000,141.490000,1425418,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-06,140.420000,141.840000,138.840000,139.190000,139.190000,2776929,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-07,139.160000,139.160000,137.140000,137.850000,137.850000,2836399,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-08,136.780000,137.785000,136.220000,137.430000,137.430000,799513,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-11,137.680000,139.600000,137.350000,139.410000,139.410000,1423400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-12,140.050000,140.250000,138.810000,139.850000,139.850000,1880472,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-13,140.720000,142.280000,140.710000,141.550000,141.550000,1093194,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-14,141.590000,142.467000,140.830000,140.980000,140.980000,712700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-15,140.660000,142.425000,140.660000,141.530000,141.530000,1938978,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-18,140.050000,143.110000,140.050000,143.080000,143.080000,1435530,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-19,143.610000,145.160000,143.310000,144.450000,144.450000,1128234,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-20,144.660000,144.670000,142.810000,143.250000,143.250000,1432897,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-21,141.430000,144.550000,140.320000,144.260000,144.260000,1604526,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-22,143.340000,144.480000,141.570000,141.650000,141.650000,1016074,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-25,141.550000,142.150000,139.760000,141.590000,141.590000,1217754,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-26,142.960000,143.980000,142.580000,143.660000,143.660000,700774,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-27,143.300000,143.810000,139.870000,141.150000,141.150000,1102350,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-28,141.800000,142.250000,140.240000,141.840000,141.840000,760698,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-03-29,142.680000,144.280000,142.090000,143.850000,143.850000,1059503,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-01,145.250000,145.600000,144.280000,144.310000,144.310000,984904,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-02,144.240000,144.970000,143.840000,144.300000,144.300000,771561,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-03,145.260000,145.720000,144.040000,144.400000,144.400000,1865014,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-04,144.840000,144.840000,140.880000,142.230000,142.230000,1738010,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-05,142.750000,144.660000,142.210000,144.260000,144.260000,1398913,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-08,144.330000,144.330000,141.885000,144.040000,144.040000,757417,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-09,143.760000,145.220000,143.490000,144.290000,144.290000,973276,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-10,144.870000,146.100000,144.390000,144.810000,144.810000,1256068,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-11,144.850000,144.850000,142.740000,143.180000,143.180000,909449,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-12,143.900000,144.650000,142.355000,142.520000,142.520000,814317,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-15,142.500000,143.150000,140.540000,141.080000,141.080000,966546,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-16,142.400000,142.480000,135.700000,136.290000,136.290000,1243017,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-17,137.360000,137.360000,131.340000,132.310000,132.310000,2170287,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-18,132.400000,134.650000,131.030000,133.010000,133.010000,1190671,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-22,132.860000,134.590000,132.210000,134.370000,134.370000,1144835,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-23,133.920000,138.100000,132.820000,137.020000,137.020000,1195240,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-24,137.000000,137.850000,134.597500,135.790000,135.790000,1240764,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-25,135.800000,137.950000,134.990000,137.360000,137.360000,1212413,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-26,137.380000,138.790000,136.260000,138.700000,138.700000,930042,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-29,139.430000,140.000000,137.730000,139.090000,139.090000,844438,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-04-30,139.280000,140.260000,138.670000,138.900000,138.900000,1127332,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-01,137.210000,137.990000,134.130000,134.990000,134.990000,1773665,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-02,134.410000,136.210000,132.730000,136.140000,136.140000,1417057,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-03,137.250000,139.120000,136.360000,138.840000,138.840000,1597501,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-06,136.870000,138.810000,136.750000,138.770000,138.770000,1189414,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-07,137.500000,138.810000,133.170000,134.370000,134.370000,1124856,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-08,134.740000,135.130000,132.840000,133.220000,133.220000,1140354,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-09,131.960000,134.050000,131.350000,133.140000,133.140000,1337529,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-10,132.460000,134.505000,130.840000,134.160000,134.160000,1648593,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-13,131.450000,133.450000,130.770000,132.280000,132.280000,1446371,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-14,133.000000,135.170000,133.000000,134.550000,134.550000,1036762,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-15,133.530000,136.490000,132.790000,135.270000,135.270000,997344,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-16,136.020000,136.590000,134.465000,135.240000,135.240000,787193,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-17,133.530000,135.480000,133.090000,133.670000,133.670000,1372548,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-20,133.330000,135.070000,132.760000,133.670000,133.670000,1022199,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-21,134.700000,135.480000,134.180000,134.570000,134.570000,699918,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-22,134.290000,135.255000,133.260000,134.820000,134.820000,1246630,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-23,133.910000,134.460000,132.180000,134.440000,134.440000,1354995,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-24,135.440000,137.620000,135.440000,136.380000,136.380000,984085,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-28,137.900000,139.025000,136.470000,136.610000,136.610000,1418541,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-29,135.780000,136.720000,134.770000,135.320000,135.320000,924742,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-30,135.640000,136.970000,135.130000,136.130000,136.130000,545951,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-05-31,134.930000,136.960000,134.390000,135.850000,135.850000,972159,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-03,136.320000,138.000000,132.810000,132.950000,132.950000,2051563,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-04,133.430000,135.740000,131.870000,135.570000,135.570000,1838287,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-05,136.930000,138.640000,136.090000,138.170000,138.170000,1283456,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-06,138.750000,140.360000,137.150000,137.410000,137.410000,871481,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-07,138.440000,139.165000,136.890000,138.740000,138.740000,889887,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-10,139.640000,140.420000,138.195000,139.720000,139.720000,1270356,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-11,140.460000,141.320000,138.640000,139.430000,139.430000,1243089,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-12,139.440000,140.230000,137.790000,139.900000,139.900000,1142596,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-13,140.320000,141.510000,139.590000,141.080000,141.080000,1574565,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-14,141.400000,143.830000,140.650000,141.300000,141.300000,1090431,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-17,141.480000,142.670000,140.980000,141.450000,141.450000,941958,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-18,143.030000,146.495000,142.270000,145.660000,145.660000,2138729,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-19,145.660000,155.130000,145.660000,154.240000,154.240000,4014272,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-20,156.880000,159.545000,153.080000,154.520000,154.520000,1865791,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-21,155.760000,158.990000,154.532500,158.670000,158.670000,2799390,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-24,157.680000,159.010000,155.595000,157.430000,157.430000,1428467,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-25,158.300000,158.510000,153.380000,154.140000,154.140000,1623864,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-26,154.200000,156.210000,152.940000,155.630000,155.630000,1520974,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-27,156.180000,157.580000,155.800000,156.630000,156.630000,657658,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-06-28,156.820000,160.910000,156.120000,160.900000,160.900000,3479000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-01,162.120000,164.130000,158.800000,160.700000,160.700000,1199738,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-02,160.510000,161.000000,157.560000,160.890000,160.890000,1100845,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-03,161.360000,161.870000,160.590000,161.460000,161.460000,794249,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-05,160.960000,161.180000,158.730000,160.900000,160.900000,814210,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-08,160.520000,160.520000,158.580000,159.140000,159.140000,1358874,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-09,158.440000,159.570000,157.660000,158.540000,158.540000,1455915,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-10,159.270000,159.990000,158.320000,159.350000,159.350000,1380244,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-11,159.280000,159.340000,157.240000,159.240000,159.240000,1046867,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-12,158.510000,159.135000,156.370000,157.360000,157.360000,783534,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-15,158.190000,158.870000,157.410000,158.400000,158.400000,586087,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-16,159.390000,159.990000,156.450000,156.570000,156.570000,715326,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-17,156.380000,157.556000,155.850000,156.020000,156.020000,861420,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-18,156.020000,157.590000,154.380000,157.280000,157.280000,1067406,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-19,157.740000,158.020000,155.300000,155.850000,155.850000,1020098,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-22,156.080000,158.140000,156.030000,156.270000,156.270000,890698,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-23,156.810000,157.160000,155.165000,156.760000,156.760000,1041135,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-24,156.720000,162.620000,154.200000,160.610000,160.610000,1946776,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-25,160.750000,161.880000,159.820000,160.090000,160.090000,1527917,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-26,160.830000,161.440000,158.640000,159.880000,159.880000,657334,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-29,159.580000,160.125000,158.098700,159.300000,159.300000,734080,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-30,158.390000,161.061600,157.100000,160.530000,160.530000,1054452,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-07-31,160.280000,161.515000,157.915000,159.170000,159.170000,1030387,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-01,159.730000,160.880000,157.280000,158.210000,158.210000,760634,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-02,157.970000,157.970000,155.670000,157.080000,157.080000,1057574,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-05,155.170000,155.170000,150.670000,151.800000,151.800000,1478419,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-06,152.660000,154.810000,151.850000,154.450000,154.450000,833392,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-07,152.990000,155.740000,151.270000,155.250000,155.250000,1114313,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-08,156.260000,158.580000,155.425000,158.100000,158.100000,941456,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-09,157.210000,157.430000,154.900000,156.000000,156.000000,2073935,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-12,155.210000,155.690000,153.560000,155.410000,155.410000,1000600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-13,153.740000,157.600000,153.740000,157.080000,157.080000,818153,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-14,154.960000,156.600000,150.220000,151.210000,151.210000,1437298,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-15,152.000000,153.860000,150.580000,152.150000,152.150000,1206371,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-16,153.870000,156.910000,153.200000,155.210000,155.210000,863379,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-19,156.660000,157.539500,155.950000,156.720000,156.720000,833899,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-20,156.920000,157.110000,154.770000,154.820000,154.820000,585161,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-21,155.890000,157.460000,154.560000,157.190000,157.190000,717401,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-22,158.490000,158.740000,155.470000,156.550000,156.550000,790992,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-23,157.800000,158.990000,152.370000,153.150000,153.150000,1083112,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-26,154.160000,155.190000,152.835000,155.120000,155.120000,707976,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-27,155.670000,155.750000,152.760000,153.660000,153.660000,1134197,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-28,153.330000,154.150000,151.720000,153.460000,153.460000,840720,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-29,155.090000,156.520000,154.460000,155.980000,155.980000,528427,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-08-30,156.740000,156.740000,153.440000,155.150000,155.150000,793253,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-03,153.780000,155.130000,153.000000,153.910000,153.910000,748499,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-04,155.370000,155.370000,151.290000,151.460000,151.460000,1258187,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-05,152.970000,154.520000,151.330000,154.080000,154.080000,1454268,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-06,154.170000,155.720000,152.750000,154.070000,154.070000,998140,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-09,154.900000,154.990000,151.670000,151.870000,151.870000,1947843,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-10,150.180000,150.780000,146.520000,150.410000,150.410000,2097064,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-11,150.000000,152.230000,148.790000,150.230000,150.230000,1597196,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-12,150.720000,151.820000,149.910000,150.730000,150.730000,1670186,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-13,149.720000,152.510000,147.310000,151.350000,151.350000,1467163,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-16,150.660000,152.840000,149.755000,150.840000,150.840000,1773042,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-17,151.100000,153.470000,149.940000,152.940000,152.940000,1909348,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-18,152.540000,153.730000,151.390000,153.440000,153.440000,1463189,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-19,153.300000,155.285000,153.140000,153.920000,153.920000,1124442,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-20,154.770000,157.320000,154.600000,155.600000,155.600000,5382869,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-23,155.130000,157.730000,154.260000,157.340000,157.340000,1763096,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-24,157.810000,158.250000,154.710000,155.420000,155.420000,1617915,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-25,154.930000,155.160000,151.085000,154.650000,154.650000,1663430,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-26,155.070000,155.070000,151.500000,151.840000,151.840000,1182571,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-27,152.470000,154.430000,146.660000,148.250000,148.250000,1666492,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-09-30,148.100000,150.250000,147.160000,149.380000,149.380000,1042840,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-01,149.870000,151.090000,143.920000,145.030000,145.030000,1704339,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-02,143.790000,144.325000,140.560000,143.240000,143.240000,1850390,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-03,143.210000,147.570000,141.700000,147.520000,147.520000,1890611,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-04,147.790000,149.910000,147.647500,149.300000,149.300000,961395,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-07,148.410000,150.120000,147.725000,148.700000,148.700000,956440,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-08,147.000000,147.000000,143.470000,144.530000,144.530000,867535,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-09,145.950000,146.630000,144.880000,145.580000,145.580000,757585,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-10,145.500000,146.800000,144.470000,144.890000,144.890000,778565,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-11,146.730000,148.970000,145.900000,145.980000,145.980000,755256,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-14,146.280000,147.930000,145.855000,146.360000,146.360000,720703,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-15,147.210000,148.690000,146.230000,146.560000,146.560000,928236,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-16,145.640000,147.470000,144.310000,144.830000,144.830000,1335681,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-17,145.650000,146.075000,142.990000,143.350000,143.350000,1108730,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-18,144.000000,145.050000,143.000000,143.490000,143.490000,1517785,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-21,144.650000,144.910000,142.040000,143.140000,143.140000,1052910,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-22,143.510000,145.420000,142.780000,142.860000,142.860000,1075554,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-23,143.140000,144.090000,142.700000,143.480000,143.480000,1198036,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-24,143.700000,146.749500,143.540000,145.170000,145.170000,1212055,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-25,144.870000,148.570000,143.950000,147.510000,147.510000,1179865,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-28,147.450000,148.800000,147.370000,147.750000,147.750000,1070544,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-29,146.730000,150.270000,146.730000,150.090000,150.090000,2091206,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-30,147.890000,147.890000,139.020000,145.740000,145.740000,3386542,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-10-31,145.720000,148.035000,143.430000,144.420000,144.420000,1091004,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-01,145.760000,147.580000,145.100000,146.740000,146.740000,985657,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-04,147.760000,147.760000,145.640000,146.500000,146.500000,937454,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-05,146.260000,146.700000,139.780000,139.890000,139.890000,1684856,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-06,139.680000,140.540000,136.280000,138.040000,138.040000,2474841,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-07,138.580000,139.270000,137.140000,137.840000,137.840000,1643056,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-08,137.380000,138.990000,136.870000,137.590000,137.590000,1451326,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-11,136.730000,140.520000,136.730000,140.520000,140.520000,1739242,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-12,139.900000,143.390000,139.900000,142.940000,142.940000,1340507,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-13,142.280000,144.060000,142.175000,143.570000,143.570000,930833,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-14,143.750000,145.910000,142.940000,145.700000,145.700000,766841,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-15,145.530000,146.595000,144.640000,146.500000,146.500000,907498,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-18,146.240000,146.240000,141.700000,142.120000,142.120000,1533916,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-19,142.320000,143.750000,142.000000,142.860000,142.860000,802460,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-20,142.410000,143.544500,141.780000,142.360000,142.360000,1905790,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-21,142.510000,144.360000,141.810000,143.480000,143.480000,1072186,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-22,144.100000,144.690000,143.110000,143.740000,143.740000,1122376,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-25,144.430000,146.510000,143.535000,146.490000,146.490000,1631305,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-26,146.060000,148.370000,145.710000,147.960000,147.960000,1622326,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-27,148.070000,148.940000,146.830000,147.520000,147.520000,1594954,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-11-29,147.140000,147.400000,145.800000,145.980000,145.980000,715690,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-02,145.980000,146.255000,143.780000,143.940000,143.940000,1175545,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-03,143.740000,144.770000,142.690000,143.340000,143.340000,1336916,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-04,143.900000,146.160000,143.800000,145.140000,145.140000,696952,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-05,145.290000,145.880000,143.320000,145.350000,145.350000,1290281,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-06,146.320000,148.899900,145.965000,148.490000,148.490000,1107832,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-09,148.230000,148.940000,146.280000,146.400000,146.400000,1412409,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-10,146.700000,146.980000,145.020000,146.120000,146.120000,1609474,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-11,146.290000,146.290000,143.430600,143.840000,143.840000,1304091,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-12,143.470000,146.040000,143.050000,145.290000,145.290000,1121464,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-13,145.260000,146.780000,144.420000,144.850000,144.850000,1162883,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-16,145.940000,147.140000,145.120000,146.530000,146.530000,1289530,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-17,147.050000,148.090000,144.900000,147.990000,147.990000,1482485,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-18,148.050000,148.320000,145.800000,147.160000,147.160000,2005418,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-19,147.090000,149.810000,146.480000,149.690000,149.690000,1638095,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-20,150.860000,156.080000,150.000000,155.950000,155.950000,3610166,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-23,156.000000,156.430000,153.240000,154.870000,154.870000,2124739,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-24,155.030000,155.120000,154.040000,154.700000,154.700000,483369,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-26,155.000000,155.000000,153.450000,154.140000,154.140000,1307260,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-27,154.650000,155.180000,154.250000,154.440000,154.440000,873921,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-30,154.470000,154.501900,152.210000,153.450000,153.450000,897936,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2019-12-31,153.310000,154.680000,153.060000,154.510000,154.510000,760894,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-02,155.230000,156.730000,153.570000,156.410000,156.410000,1925893,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-03,153.970000,154.950000,153.730000,154.190000,154.190000,1047163,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-06,153.120000,155.090000,152.170000,155.000000,155.000000,1539150,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-07,155.780000,157.900000,155.380000,156.800000,156.800000,1052869,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-08,157.070000,159.250000,156.825000,157.600000,157.600000,1182144,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-09,158.290000,159.840000,158.080000,159.500000,159.500000,850441,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-10,160.200000,160.860000,158.970000,159.300000,159.300000,876403,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-13,159.630000,159.630000,157.575000,158.150000,158.150000,1885061,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-14,157.490000,159.090000,156.760000,158.930000,158.930000,1089547,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-15,158.860000,160.590000,158.290000,159.370000,159.370000,950008,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-16,160.450000,161.100000,159.800000,160.970000,160.970000,750744,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-17,161.450000,161.690000,159.390000,161.510000,161.510000,777413,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-21,161.090000,161.860000,160.260000,160.850000,160.850000,979908,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-22,161.070000,162.140000,160.440000,160.500000,160.500000,733812,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-23,160.320000,161.030000,159.285000,160.910000,160.910000,811664,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-24,161.620000,162.140000,157.780000,158.100000,158.100000,821432,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-27,156.140000,158.180000,155.840000,157.160000,157.160000,754916,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-28,157.860000,159.569100,156.740000,158.670000,158.670000,854554,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-29,158.850000,160.325000,158.405000,158.500000,158.500000,821091,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-30,157.140000,158.140000,155.620000,157.000000,157.000000,1594972,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-01-31,156.630000,157.190000,154.450000,155.250000,155.250000,1143230,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-03,156.600000,157.218100,154.940000,155.250000,155.250000,1786059,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-04,157.120000,157.590000,155.620000,157.040000,157.040000,3384339,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-05,159.060000,161.550000,158.380000,159.760000,159.760000,1373281,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-06,160.640000,161.250000,159.790000,160.530000,160.530000,976618,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-07,160.310000,160.610000,156.980000,157.000000,157.000000,1193042,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-10,157.000000,160.140000,156.520000,159.930000,159.930000,1303778,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-11,160.990000,163.515000,160.210000,161.700000,161.700000,1582595,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-12,164.850000,169.140000,160.000000,166.110000,166.110000,2302381,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-13,164.800000,166.030000,162.640000,165.790000,165.790000,1439956,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-14,165.300000,165.500000,162.170000,164.320000,164.320000,2967361,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-18,164.910000,165.740000,162.610000,165.420000,165.420000,1436201,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-19,166.280000,166.280000,164.125000,164.390000,164.390000,1070708,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-20,163.500000,164.326400,162.170000,164.140000,164.140000,1574310,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-21,163.480000,164.350000,161.575000,163.430000,163.430000,967908,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-24,159.420000,160.265000,156.630000,158.080000,158.080000,1313101,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-25,158.930000,159.100000,149.500000,150.060000,150.060000,2918784,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-26,151.370000,154.370000,148.940000,149.390000,149.390000,1667780,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-27,147.190000,148.740000,142.630000,142.740000,142.740000,3406937,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-02-28,138.910000,141.240000,136.230000,139.490000,139.490000,3112235,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-02,140.730000,147.230000,139.310000,147.080000,147.080000,2504941,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-03,147.440000,150.250000,139.530000,141.360000,141.360000,1557197,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-04,144.860000,148.445000,144.500000,147.890000,147.890000,1228700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-05,143.840000,144.775000,136.510000,138.210000,138.210000,2214990,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-06,136.300000,138.300000,131.390000,136.050000,136.050000,2110569,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-09,129.460000,131.140000,122.970000,124.000000,124.000000,2760829,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-10,128.180000,131.140000,122.770000,130.820000,130.820000,2721815,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-11,126.630000,128.240000,123.260000,125.420000,125.420000,2112994,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-12,116.720000,117.360000,110.350000,113.010000,113.010000,2910971,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-13,119.790000,120.600000,111.080000,118.710000,118.710000,2244627,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-16,99.160000,106.250000,94.200000,102.360000,102.360000,5128914,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-17,104.090000,110.540000,101.050000,107.690000,107.690000,3699856,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-18,100.440000,100.990000,81.790000,89.880000,89.880000,4695580,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-19,88.830000,104.830000,82.000000,90.620000,90.620000,3712016,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-20,91.793500,99.730000,89.567400,91.670000,91.670000,2987842,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-23,92.000000,92.000000,82.030000,84.000000,84.000000,2740882,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-24,89.470000,97.090000,88.080000,96.910000,96.910000,2750435,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-25,97.230000,111.630000,94.160000,104.880000,104.880000,3646422,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-26,106.940000,116.370000,106.490000,110.550000,110.550000,2865269,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-27,105.720000,108.450000,100.890000,107.140000,107.140000,3063690,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-30,106.960000,114.750000,105.030000,112.980000,112.980000,1627212,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-03-31,111.800000,113.610000,105.210000,107.860000,107.860000,2853185,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-01,102.020000,104.210000,98.010000,100.040000,100.040000,2084252,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-02,100.460000,105.400000,99.070000,104.780000,104.780000,1708641,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-03,104.550000,108.625000,101.000000,102.720000,102.720000,2687671,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-06,109.570000,119.090000,108.300000,117.140000,117.140000,2061738,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-07,124.220000,124.990000,116.910000,119.680000,119.680000,2148605,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-08,120.740000,129.500000,117.570000,127.870000,127.870000,1634372,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-09,128.300000,132.180000,127.700000,128.530000,128.530000,1522884,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-13,127.400000,127.680000,121.340400,124.790000,124.790000,1980811,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-14,127.220000,129.000000,125.460000,126.490000,126.490000,1414960,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-15,123.390000,124.540000,121.220000,124.020000,124.020000,1327512,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-16,124.780000,125.790000,122.160000,124.460000,124.460000,973336,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-17,128.030000,131.760000,127.720000,131.570000,131.570000,1486284,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-20,128.720000,131.250000,127.410000,127.510000,127.510000,1180091,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-21,124.260000,125.680000,121.355000,122.000000,122.000000,1077192,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-22,124.970000,126.580000,122.220000,125.550000,125.550000,634343,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-23,126.770000,131.740000,126.010000,127.670000,127.670000,822642,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-24,128.060000,129.630000,126.350000,128.860000,128.860000,767608,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-27,130.000000,132.490000,129.900000,131.880000,131.880000,1276203,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-28,138.500000,147.410000,130.460000,135.880000,135.880000,2204959,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-29,139.720000,143.450000,138.170500,143.100000,143.100000,1428149,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-04-30,141.390000,143.660000,140.170000,142.590000,142.590000,1790526,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-01,139.050000,140.780000,135.320000,136.520000,136.520000,1205018,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-04,135.100000,135.770000,131.400000,134.060000,134.060000,1070563,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-05,135.970000,137.205000,134.770000,135.490000,135.490000,924383,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-06,135.990000,137.360000,133.860000,134.010000,134.010000,728323,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-07,136.670000,137.470000,135.247500,135.520000,135.520000,868852,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-08,138.060000,139.350000,136.850000,137.650000,137.650000,677936,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-11,136.540000,139.050000,135.340000,138.650000,138.650000,814758,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-12,139.000000,139.398600,134.700000,134.800000,134.800000,678390,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-13,135.020000,136.550000,131.420000,132.470000,132.470000,1174875,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-14,130.590000,132.970000,128.520000,132.370000,132.370000,1224775,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-15,131.870000,134.350000,130.715000,134.200000,134.200000,1133710,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-18,138.600000,140.850000,138.000000,138.560000,138.560000,850278,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-19,138.100000,141.800000,137.730000,140.860000,140.860000,2707559,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-20,142.200000,145.730000,141.635000,145.420000,145.420000,1245096,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-21,145.200000,146.380000,142.450000,143.200000,143.200000,1326402,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-22,143.440000,144.020000,141.760000,142.900000,142.900000,682879,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-26,146.620000,147.420000,143.060000,143.500000,143.500000,1468674,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-27,145.700000,147.170000,141.870000,146.820000,146.820000,1015976,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-28,147.990000,149.280000,145.710000,146.200000,146.200000,942701,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-05-29,146.690000,150.345000,146.160000,149.520000,149.520000,2904505,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-01,149.100000,150.010000,147.010000,149.410000,149.410000,884787,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-02,149.850000,151.750000,148.390000,151.530000,151.530000,1199997,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-03,151.830000,154.630000,151.190000,153.060000,153.060000,1234282,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-04,151.220000,152.740000,150.200000,151.210000,151.210000,1086867,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-05,154.630000,156.225000,148.800000,149.580000,149.580000,1731007,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-08,148.620000,151.380000,148.430000,150.000000,150.000000,1376130,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-09,148.640000,149.560000,146.600000,146.800000,146.800000,815007,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-10,147.270000,148.800000,144.660000,147.190000,147.190000,1209036,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-11,143.570000,143.840000,138.220000,138.640000,138.640000,1491211,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-12,142.590000,143.590000,134.930000,138.820000,138.820000,990199,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-15,135.210000,140.260000,135.190000,139.570000,139.570000,1277711,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-16,143.640000,144.460000,139.570000,141.040000,141.040000,1297231,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-17,141.500000,141.500000,138.040000,138.920000,138.920000,1322875,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-18,138.020000,139.250000,136.895000,138.120000,138.120000,1162015,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-19,141.170000,141.310000,136.060000,136.080000,136.080000,2453099,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-22,135.830000,137.913600,133.930500,137.530000,137.530000,1477108,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-23,139.190000,142.020000,136.850000,140.170000,140.170000,2005952,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-24,139.100000,139.780000,134.380000,136.470000,136.470000,1476850,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-25,136.030000,137.970000,133.180000,137.800000,137.800000,1229311,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-26,136.880000,139.060000,135.470000,135.990000,135.990000,1712280,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-29,136.940000,137.710000,135.630000,137.520000,137.520000,562400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-06-30,137.000000,142.560000,137.000000,141.880000,141.880000,883500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-01,141.980000,142.680000,139.400000,141.530000,141.530000,1427000,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-02,143.220000,144.000000,140.870000,141.520000,141.520000,777200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-06,143.300000,144.030000,141.720000,143.640000,143.640000,1171800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-07,142.560000,144.440000,141.740000,141.940000,141.940000,817900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-08,142.560000,144.420000,142.310000,144.170000,144.170000,783700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-09,143.970000,145.950000,142.720000,144.990000,144.990000,742800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-10,145.030000,145.310000,141.390000,142.680000,142.680000,761900,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-13,144.220000,146.350000,141.150000,141.280000,141.280000,816100,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-14,141.800000,147.990000,140.600000,147.780000,147.780000,1320300,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-15,150.000000,152.890000,149.260000,152.370000,152.370000,1004200,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-16,151.850000,151.850000,148.160000,149.680000,149.680000,940800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-17,150.940000,155.070000,149.910000,154.050000,154.050000,968700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-20,153.620000,155.570000,153.030000,155.200000,155.200000,945877,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-21,156.190000,159.240000,155.920000,156.950000,156.950000,1443693,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-22,160.060000,166.160000,160.000000,164.290000,164.290000,1836685,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-23,164.700000,164.990000,160.550000,161.480000,161.480000,1937950,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-24,160.570000,161.000000,156.460000,157.880000,157.880000,1071906,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-27,158.420000,163.550000,158.010000,162.280000,162.280000,1047716,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-28,158.750000,160.930000,157.720000,158.650000,158.650000,1677596,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-29,159.650000,160.880000,159.020000,160.060000,160.060000,1170793,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-30,158.000000,159.090000,156.165000,158.260000,158.260000,893062,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-07-31,158.000000,158.630000,155.710000,158.390000,158.390000,1014030,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-03,159.070000,161.970000,158.460000,161.180000,161.180000,743819,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-04,160.110000,160.840000,159.000000,160.150000,160.150000,889951,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-05,161.500000,161.820000,159.670000,160.750000,160.750000,724006,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-06,161.000000,161.680000,159.490000,161.040000,161.040000,1150906,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-07,160.050000,161.040000,159.010000,160.540000,160.540000,680875,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-10,160.850000,160.930000,158.970000,159.640000,159.640000,794226,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-11,160.410000,161.960000,158.965000,159.310000,159.310000,718255,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-12,160.220000,163.380000,159.920000,162.870000,162.870000,785761,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-13,162.220000,165.020000,162.220000,163.750000,163.750000,682331,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-14,162.650000,162.880000,160.480000,161.230000,161.230000,560327,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-17,161.820000,163.260000,161.150000,161.500000,161.500000,488133,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-18,161.810000,161.810000,159.430000,160.530000,160.530000,529819,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-19,160.670000,161.680000,159.090000,160.160000,160.160000,396794,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-20,158.950000,158.950000,157.430000,157.960000,157.960000,651106,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-21,158.520000,158.700000,156.342700,157.570000,157.570000,661182,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-24,158.430000,158.530000,155.090000,156.240000,156.240000,990103,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-25,156.910000,157.790000,154.580000,156.940000,156.940000,1149214,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-26,156.660000,159.150000,156.660000,158.520000,158.520000,745744,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-27,158.400000,159.940000,156.520000,158.500000,158.500000,917926,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-28,158.500000,161.250000,157.820000,161.220000,161.220000,684819,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-08-31,160.640000,164.880000,160.250000,163.750000,163.750000,1304064,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-01,164.000000,165.880000,163.000000,165.130000,165.130000,959205,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-02,165.520000,170.510000,164.650000,169.750000,169.750000,972304,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-03,169.960000,169.990000,163.125000,164.800000,164.800000,796922,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-04,165.540000,165.710000,157.175000,160.210000,160.210000,1152533,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-08,158.620000,161.560000,157.200000,157.790000,157.790000,1041066,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-09,160.740000,163.180000,159.430000,161.060000,161.060000,974699,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-10,162.000000,163.740000,159.500000,159.670000,159.670000,923515,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-11,160.960000,161.630000,158.140000,159.530000,159.530000,545567,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-14,161.610000,163.110000,160.680000,161.650000,161.650000,766018,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-15,162.730000,165.750000,162.730000,164.710000,164.710000,1242451,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-16,165.600000,165.910000,162.000000,162.010000,162.010000,1268029,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-17,160.790000,161.310000,158.590000,160.500000,160.500000,1019676,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-18,160.380000,160.880000,156.715000,157.120000,157.120000,3615928,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-21,154.620000,154.920000,150.610000,154.080000,154.080000,1251212,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-22,153.770000,154.440000,152.500000,153.300000,153.300000,1157693,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-23,153.350000,153.770000,148.870000,148.960000,148.960000,809883,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-24,149.750000,149.750000,146.000000,148.070000,148.070000,1080988,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-25,147.320000,152.525000,146.030000,151.300000,151.300000,1792720,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-28,153.500000,156.990000,153.500000,155.310000,155.310000,910630,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-29,155.250000,158.050000,154.610000,154.780000,154.780000,858618,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-09-30,155.440000,158.970000,155.000000,157.630000,157.630000,778727,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-01,159.160000,160.800000,157.475000,158.330000,158.330000,799022,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-02,156.410000,158.380000,155.810000,156.830000,156.830000,561671,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-05,158.600000,161.650000,157.810000,160.620000,160.620000,560291,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-06,161.150000,162.920000,159.400000,159.400000,159.400000,472907,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-07,160.320000,164.720000,160.320000,164.190000,164.190000,579827,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-08,164.570000,166.105000,163.830000,164.490000,164.490000,561119,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-09,165.380000,167.540000,164.970000,166.760000,166.760000,926540,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-12,167.940000,171.880000,166.490000,170.460000,170.460000,923112,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-13,169.500000,170.990000,166.570000,166.590000,166.590000,815128,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-14,167.370000,168.130000,164.285000,165.890000,165.890000,771519,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-15,163.530000,164.190000,161.350000,162.000000,162.000000,1173588,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-16,163.330000,166.390000,163.330000,164.560000,164.560000,1047542,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-19,164.770000,166.500000,163.070000,164.050000,164.050000,1361330,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-20,172.160000,176.000000,171.840000,173.500000,173.500000,2158941,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-21,173.900000,174.720000,169.080000,169.250000,169.250000,918478,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-22,169.870000,171.980000,167.490000,169.400000,169.400000,946112,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-23,170.770000,170.770000,166.530000,167.470000,167.470000,760587,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-26,165.330000,165.710000,159.810000,162.170000,162.170000,1301288,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-27,162.620000,162.740000,158.580000,159.140000,159.140000,1216821,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-28,155.750000,158.640000,155.219500,155.710000,155.710000,1400227,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-29,156.420000,157.750000,153.550000,154.650000,154.650000,1226196,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-10-30,153.940000,155.010000,150.655000,153.990000,153.990000,1009747,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-02,156.210000,157.570000,154.237500,155.130000,155.130000,787894,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-03,157.660000,160.950000,157.090100,160.140000,160.140000,765493,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-04,162.040000,174.210000,162.040000,170.900000,170.900000,1583556,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-05,173.670000,176.160000,171.260000,171.710000,171.710000,1007062,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-06,171.990000,173.330000,169.860000,171.440000,171.440000,759529,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-09,180.130000,180.769400,173.310000,173.660000,173.660000,1276280,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-10,172.760000,173.410000,165.485000,166.000000,166.000000,1272435,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-11,168.010000,169.710000,165.580000,167.880000,167.880000,885016,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-12,167.810000,169.650000,166.680000,167.800000,167.800000,746397,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-13,168.980000,174.520000,168.970000,173.930000,173.930000,745397,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-16,175.000000,175.380000,171.890000,173.740000,173.740000,620012,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-17,171.780000,172.400000,168.910000,172.210000,172.210000,613112,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-18,172.320000,173.530000,168.870000,169.070000,169.070000,837107,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-19,168.350000,169.845000,167.010000,169.550000,169.550000,713982,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-20,169.750000,171.080000,168.140000,169.770000,169.770000,606018,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-23,170.800000,171.420000,169.310000,170.560000,170.560000,682754,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-24,173.050000,173.820000,170.775000,172.000000,172.000000,719875,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-25,171.990000,171.990000,169.340000,169.870000,169.870000,817074,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-27,170.480000,170.890000,168.030000,168.810000,168.810000,591766,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-11-30,169.610000,170.420000,167.740000,168.990000,168.990000,1643998,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-01,170.620000,173.770000,170.310000,171.230000,171.230000,1293389,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-02,170.300000,170.810000,168.310000,170.040000,170.040000,1050745,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-03,170.500000,171.000000,167.190000,167.630000,167.630000,1560082,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-04,167.900000,170.610000,165.820000,170.610000,170.610000,1496028,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-07,170.690000,172.140000,169.140000,170.070000,170.070000,1660166,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-08,169.440000,171.450000,168.380000,171.290000,171.290000,1579895,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-09,171.180000,171.500000,168.390000,168.500000,168.500000,1086126,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-10,168.400000,169.980000,167.430000,168.470000,168.470000,866332,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-11,167.400000,168.590000,165.520000,167.810000,167.810000,1069165,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-14,169.080000,172.250000,166.910000,167.300000,167.300000,1090972,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-15,168.720000,173.340000,167.670000,172.420000,172.420000,1490631,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-16,172.420000,175.460000,171.070000,174.690000,174.690000,1124461,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-17,175.730000,179.220000,175.000000,178.950000,178.950000,1884445,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-18,179.580000,180.990000,177.660000,180.390000,180.390000,1901537,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-21,177.310000,177.970000,173.870000,176.750000,176.750000,1396710,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-22,177.370000,177.370000,174.605000,176.980000,176.980000,856379,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-23,177.840000,178.990000,174.900000,175.550000,175.550000,894659,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-24,175.910000,176.460000,174.940000,175.940000,175.940000,261761,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-28,177.500000,177.500000,173.825000,175.320000,175.320000,559644,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-29,177.490000,177.522500,174.310000,174.830000,174.830000,441512,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-30,175.550000,178.580000,175.200000,177.520000,177.520000,871881,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2020-12-31,178.040000,179.370000,175.390000,179.170000,179.170000,528778,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-04,178.440000,179.810000,174.280000,176.600000,176.600000,1046500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-05,175.730000,180.330000,175.730000,179.340000,179.340000,775057,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-06,177.130000,187.050000,176.995000,186.250000,186.250000,1123842,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-07,187.800000,189.810000,187.320000,188.060000,188.060000,741303,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-08,188.000000,192.000000,187.530000,191.080000,191.080000,805452,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-11,190.070000,192.070000,188.270000,191.440000,191.440000,617112,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-12,191.000000,192.340000,187.940000,189.420000,189.420000,607658,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-13,189.040000,191.370000,188.960000,189.360000,189.360000,529238,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-14,189.380000,190.550000,187.700000,188.110000,188.110000,568215,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-15,187.920000,188.750000,185.610000,187.790000,187.790000,1028155,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-19,191.500000,191.500000,186.470000,188.970000,188.970000,948304,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-20,189.030000,191.270000,188.030000,190.540000,190.540000,684115,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-21,189.650000,191.270000,187.630000,187.690000,187.690000,1154478,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-22,186.990000,187.410000,185.130000,185.590000,185.590000,823954,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-25,185.750000,186.438800,179.530000,183.020000,183.020000,930592,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-26,184.480000,184.680000,180.060000,180.340000,180.340000,755075,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-27,176.120000,176.845000,170.000000,173.000000,173.000000,1574211,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-28,175.940000,180.340000,174.910000,178.660000,178.660000,1028362,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-01-29,178.050000,181.750000,176.510000,177.800000,177.800000,881212,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-01,180.180000,182.200000,178.830000,180.440000,180.440000,1251611,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-02,183.150000,187.340000,182.250000,184.410000,184.410000,950662,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-03,183.910000,185.500000,182.350000,182.990000,182.990000,724762,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-04,183.360000,185.970000,182.030000,184.320000,184.320000,654499,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-05,186.030000,187.000000,184.830000,186.100000,186.100000,932266,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-08,187.470000,189.080000,186.415000,186.910000,186.910000,1344112,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-09,185.640000,187.139900,183.790000,183.820000,183.820000,1126909,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-10,195.750000,199.990000,189.590000,190.050000,190.050000,2058069,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-11,191.660000,196.965000,191.310000,192.850000,192.850000,1051894,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-12,191.570000,193.220000,188.900000,192.660000,192.660000,755423,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-16,192.660000,193.160000,189.670000,190.500000,190.500000,1060943,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-17,188.510000,191.670000,188.220000,188.930000,188.930000,469797,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-18,188.000000,189.030000,185.380000,187.710000,187.710000,713227,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-19,188.400000,189.450000,185.970000,188.700000,188.700000,788636,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-22,187.450000,190.790000,186.385000,190.140000,190.140000,782805,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-23,190.670000,192.810000,189.890000,191.050000,191.050000,1262176,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-24,191.180000,197.350000,191.180000,194.590000,194.590000,1350345,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-25,194.050000,195.000000,190.675000,192.550000,192.550000,1111212,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-02-26,193.820000,195.270000,189.390000,192.790000,192.790000,1376241,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-01,194.980000,196.720000,192.550000,194.390000,194.390000,823944,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-02,194.330000,194.790000,190.120000,192.740000,192.740000,609582,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-03,191.170000,192.435000,188.610000,190.590000,190.590000,638351,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-04,189.710000,191.260000,183.907300,186.580000,186.580000,857683,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-05,187.870000,189.920000,181.130000,188.780000,188.780000,1216587,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-08,191.470000,194.950000,187.620000,187.800000,187.800000,917474,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-09,190.060000,192.795000,188.810000,189.390000,189.390000,862663,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-10,190.240000,191.790000,189.540000,189.740000,189.740000,676971,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-11,191.360000,191.830000,189.080000,189.370000,189.370000,677500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-12,188.140000,189.220000,185.250000,186.810000,186.810000,886739,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-15,186.030000,190.720000,185.840000,190.650000,190.650000,808706,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-16,191.770000,192.790000,187.340000,189.390000,189.390000,846535,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-17,188.690000,191.100000,187.610000,189.710000,189.710000,726754,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-18,188.530000,190.050000,185.730000,186.500000,186.500000,771828,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-19,187.090000,189.620000,185.780000,188.330000,188.330000,1090587,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-22,188.300000,191.060000,187.140000,189.730000,189.730000,878104,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-23,189.530000,189.770000,186.370000,186.990000,186.990000,800262,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-24,187.260000,189.230000,185.550000,186.110000,186.110000,584995,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-25,186.290000,187.040000,184.305000,186.550000,186.550000,900904,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-26,187.850000,193.160000,186.650000,192.860000,192.860000,604982,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-29,191.040000,192.230000,189.700000,191.000000,191.000000,595198,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-30,189.700000,191.735000,189.150000,190.790000,190.790000,758788,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-03-31,192.140000,195.060000,190.850000,193.140000,193.140000,862548,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-01,195.030000,199.310000,191.840000,198.060000,198.060000,1003018,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-05,199.000000,201.310000,199.000000,200.370000,200.370000,604786,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-06,200.300000,203.790000,200.200000,203.570000,203.570000,850432,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-07,203.430000,203.440000,200.070000,201.600000,201.600000,639707,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-08,202.460000,204.905000,202.460000,204.340000,204.340000,641912,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-09,205.680000,207.790000,204.660000,207.660000,207.660000,567052,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-12,207.900000,208.480000,205.775000,208.210000,208.210000,929421,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-13,208.090000,208.840000,206.690000,207.490000,207.490000,505925,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-14,208.620000,211.110000,207.860000,208.900000,208.900000,814473,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-15,210.750000,217.629900,210.750000,214.130000,214.130000,1129679,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-16,216.000000,216.910000,214.811500,215.560000,215.560000,1413998,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-19,215.710000,218.330000,214.960000,216.220000,216.220000,1205754,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-20,215.870000,219.600000,215.870000,217.120000,217.120000,1854739,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-21,216.500000,220.550000,215.220000,219.000000,219.000000,986318,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-22,225.950000,235.510000,223.600000,225.940000,225.940000,1829480,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-23,226.400000,232.910000,226.400000,232.300000,232.300000,1594658,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-26,233.090000,235.190000,232.180000,233.420000,233.420000,1291798,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-27,233.320000,234.660000,231.692000,234.410000,234.410000,1339881,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-28,233.770000,237.290000,232.747500,236.020000,236.020000,1165511,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-29,237.000000,237.470000,232.120000,235.450000,235.450000,1045431,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-04-30,235.110000,236.920000,232.590000,234.690000,234.690000,774084,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-03,236.000000,236.620000,231.725000,233.960000,233.960000,793177,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-04,232.000000,233.670000,229.470000,232.690000,232.690000,1069202,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-05,233.550000,234.150000,231.460000,231.940000,231.940000,951260,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-06,231.330000,231.740000,229.350000,231.220000,231.220000,1250363,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-07,232.000000,236.210000,231.860000,234.390000,234.390000,953261,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-10,234.960000,235.860000,231.280000,231.490000,231.490000,1024070,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-11,229.310000,233.300000,227.400000,232.070000,232.070000,1131869,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-12,229.860000,231.760000,227.590000,228.000000,228.000000,775166,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-13,229.070000,230.970000,228.190000,229.660000,229.660000,968748,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-14,231.080000,234.805000,229.360000,234.040000,234.040000,785385,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-17,234.650000,235.540000,231.220000,231.480000,231.480000,565856,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-18,232.150000,232.290000,229.530000,230.580000,230.580000,1046144,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-19,228.120000,232.720000,226.951000,232.700000,232.700000,941181,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-20,232.390000,237.840000,232.030000,236.740000,236.740000,656783,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-21,237.350000,240.820000,237.350000,238.960000,238.960000,1002491,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-24,241.130000,243.940000,239.910000,242.580000,242.580000,737965,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-25,243.440000,244.954600,241.230000,242.130000,242.130000,827494,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-26,243.190000,243.690000,237.630000,239.600000,239.600000,664747,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-27,239.950000,240.900000,237.280600,237.460000,237.460000,2468127,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-05-28,239.550000,240.580000,238.020000,240.160000,240.160000,1282804,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-01,241.400000,242.010000,234.760000,237.250000,237.250000,847833,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-02,238.380000,239.495000,234.910000,235.000000,235.000000,944955,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-03,233.380000,234.838300,230.960000,233.340000,233.340000,1490067,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-04,235.590000,236.430000,233.450000,233.840000,233.840000,919542,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-07,233.570000,235.220000,232.580000,233.200000,233.200000,1608560,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-08,234.050000,235.715000,231.070000,234.820000,234.820000,777082,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-09,235.200000,239.850000,234.650000,239.380000,239.380000,1049859,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-10,239.950000,244.380000,239.920000,242.800000,242.800000,799852,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-11,243.000000,243.540000,240.477500,243.440000,243.440000,1090256,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-14,243.410000,245.505000,242.300000,244.470000,244.470000,726699,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-15,245.210000,247.480000,244.180100,246.770000,246.770000,950115,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-16,248.740000,248.740000,243.770000,244.230000,244.230000,985528,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-17,243.860000,247.060000,243.120000,246.300000,246.300000,1136143,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-18,244.650000,247.060000,238.990000,239.660000,239.660000,4072064,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-21,241.110000,244.275000,239.100000,243.450000,243.450000,1065508,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-22,243.420000,244.950000,241.910000,243.980000,243.980000,1049968,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-23,243.090000,244.639900,241.580600,242.310000,242.310000,984835,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-24,243.580000,244.820000,240.810000,240.890000,240.890000,925060,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-25,241.930000,245.770000,240.890000,245.340000,245.340000,1840548,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-28,245.930000,246.741400,242.160000,243.390000,243.390000,631161,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-29,243.140000,245.620000,242.580000,244.090000,244.090000,547365,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-06-30,243.340000,243.990000,240.330000,242.320000,242.320000,1051499,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-01,242.730000,247.350000,242.460000,247.140000,247.140000,910413,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-02,247.410000,249.450000,246.150000,249.150000,249.150000,538746,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-06,249.640000,251.570000,247.840000,250.950000,250.950000,1113796,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-07,251.670000,254.050000,248.980000,253.940000,253.940000,830548,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-08,250.000000,250.605000,247.905000,248.810000,248.810000,750082,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-09,249.700000,251.310000,248.570000,251.160000,251.160000,470576,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-12,251.630000,252.410000,248.110000,248.620000,248.620000,765700,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-13,248.990000,250.045000,246.500000,249.630000,249.630000,734752,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-14,249.640000,250.460000,245.310000,246.000000,246.000000,681517,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-15,245.630000,247.220000,243.910000,246.500000,246.500000,717869,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-16,247.300000,249.775000,245.663100,247.700000,247.700000,501252,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-19,244.230000,245.150000,239.830000,241.690000,241.690000,906436,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-20,242.920000,247.690000,241.480000,247.070000,247.070000,1123819,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-21,247.880000,247.880000,241.315000,243.030000,243.030000,1139846,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-22,244.160000,246.885000,243.430000,244.910000,244.910000,714275,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-23,246.010000,249.910000,245.280000,249.080000,249.080000,839077,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-26,248.050000,249.850000,243.925000,247.290000,247.290000,1293876,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-27,243.630000,247.200000,238.170000,243.180000,243.180000,1556834,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-28,244.160000,246.280000,242.020000,245.370000,245.370000,1168889,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-29,246.820000,250.200000,246.515000,248.710000,248.710000,585778,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-07-30,248.920000,249.910000,247.130000,247.700000,247.700000,966961,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-02,248.430000,249.425000,246.300000,247.300000,247.300000,807041,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-03,248.190000,250.740000,247.780000,249.980000,249.980000,1049872,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-04,249.990000,252.130000,246.800000,249.860000,249.860000,727655,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-05,250.900000,251.850000,247.270000,248.410000,248.410000,508771,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-06,247.820000,249.805200,244.805000,248.960000,248.960000,670918,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-09,249.090000,249.830000,245.380000,247.660000,247.660000,541872,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-10,247.460000,249.910000,245.720000,247.390000,247.390000,543726,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-11,247.630000,248.440000,244.210000,244.550000,244.550000,530724,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-12,244.970000,247.150000,243.685000,246.250000,246.250000,553727,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-13,246.600000,248.260000,245.985000,248.140000,248.140000,265601,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-16,248.400000,255.450000,248.230000,255.290000,255.290000,677690,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-17,254.620000,257.300000,253.065000,257.040000,257.040000,859991,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-18,256.920000,259.080000,254.880000,255.000000,255.000000,801880,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-19,253.210000,257.270000,252.834100,256.660000,256.660000,865675,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-20,256.470000,257.970000,253.310000,254.700000,254.700000,555600,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-23,256.880000,257.730000,253.810000,254.380000,254.380000,707182,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-24,255.264000,257.260000,253.565000,256.860000,256.860000,675274,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-25,257.970000,259.298100,255.640000,258.710000,258.710000,383352,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-26,258.640000,259.780000,256.400000,258.490000,258.490000,442599,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-27,259.420000,263.610000,259.020000,259.550000,259.550000,459122,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-30,259.080000,261.750000,259.080000,261.600000,261.600000,509027,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-08-31,261.600000,262.250000,258.250000,259.730000,259.730000,638778,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-01,260.010000,263.050000,258.480000,262.230000,262.230000,514499,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-02,263.660000,265.340000,262.760000,265.230000,265.230000,476814,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-03,264.720000,264.810000,262.560000,263.220000,263.220000,509689,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-07,261.930000,265.100000,259.440100,264.450000,264.450000,474502,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-08,264.300000,265.300000,261.629600,261.910000,261.910000,611800,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-09,262.000000,263.850000,260.874600,261.280000,261.280000,480831,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-10,262.390000,263.940000,259.290000,260.500000,260.500000,455614,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-13,262.140000,262.535000,253.170000,255.570000,255.570000,672545,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-14,257.460000,259.650000,256.000000,257.550000,257.550000,711203,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-15,257.070000,259.095000,255.890000,258.550000,258.550000,531421,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-16,258.600000,259.280000,256.690000,257.850000,257.850000,508535,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-17,257.630000,259.030000,254.820000,256.330000,256.330000,929123,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-20,252.810000,255.220000,249.826600,253.170000,253.170000,488174,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-21,254.920000,258.480000,253.950000,256.260000,256.260000,619822,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-22,257.150000,261.360000,255.610000,259.750000,259.750000,545456,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-23,261.060000,264.010000,258.570000,262.270000,262.270000,748104,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-24,261.910000,263.520000,259.040100,261.610000,261.610000,715939,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-27,260.270000,260.600000,246.800000,248.140000,248.140000,1242312,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-28,245.080000,245.255000,237.450100,241.590000,241.590000,1403909,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-29,244.520000,245.100000,241.970000,242.910000,242.910000,758419,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-09-30,244.090000,245.480000,239.129000,239.540000,239.540000,867236,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-01,239.740000,242.980000,234.100000,241.550000,241.550000,674611,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-04,241.490000,243.290000,234.770000,238.570000,238.570000,901795,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-05,240.270000,243.470000,237.720000,239.360000,239.360000,649077,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-06,237.880000,239.860000,235.990000,239.400000,239.400000,539931,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-07,240.680000,246.180000,240.280000,243.820000,243.820000,528871,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-08,244.350000,244.450000,241.580000,242.230000,242.230000,548595,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-11,241.170000,244.775000,240.090000,240.280000,240.280000,317997,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-12,242.220000,242.270000,237.570000,238.370000,238.370000,309829,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-13,239.940000,243.650000,239.280000,241.510000,241.510000,750977,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-14,244.070000,247.250000,244.020000,246.820000,246.820000,534824,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-15,248.310000,250.311300,246.570000,248.850000,248.850000,567322,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-18,248.300000,249.610000,246.180000,248.460000,248.460000,550009,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-19,250.590000,252.970000,248.900000,249.020000,249.020000,616207,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-20,249.800000,253.650000,249.740000,251.520000,251.520000,768046,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-21,250.000000,255.720000,241.300000,254.840000,254.840000,1308326,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-22,256.000000,260.120000,254.870000,256.890000,256.890000,987574,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-25,256.790000,258.310000,255.215000,257.250000,257.250000,701138,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-26,258.340000,258.810000,255.755000,256.090000,256.090000,566262,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-27,257.450000,257.450000,254.040000,254.290000,254.290000,548493,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-28,254.380000,258.070000,253.680000,257.190000,257.190000,487262,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-10-29,256.930000,261.960000,255.705000,261.420000,261.420000,676987,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-01,261.820000,263.690000,257.170100,258.890000,258.890000,551525,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-02,259.840000,259.990000,255.890000,257.830000,257.830000,589661,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-03,257.470000,257.470000,248.160000,254.600000,254.600000,1021791,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-04,254.620000,254.900000,251.670000,253.860000,253.860000,808274,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-05,252.050000,252.580000,245.110000,247.190000,247.190000,1402537,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-08,248.570000,251.630000,246.830000,251.500000,251.500000,683985,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-09,252.160000,254.620000,249.715000,251.800000,251.800000,599384,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-10,250.450000,255.780000,250.450000,252.120000,252.120000,570889,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-11,253.200000,254.120000,249.880000,252.580000,252.580000,680896,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-12,254.610000,256.570000,251.650000,254.680000,254.680000,857383,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-15,254.910000,256.600000,250.900000,251.810000,251.810000,956157,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-16,252.180000,268.520000,251.300000,267.540000,267.540000,1264034,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-17,269.000000,269.000000,263.510000,264.450000,264.450000,920149,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-18,267.230000,271.320000,266.010000,266.600000,266.600000,1225055,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-19,268.970000,272.250000,267.680000,268.170000,268.170000,942954,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-22,269.110000,269.600000,266.110000,267.490000,267.490000,779875,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-23,264.860000,265.580000,261.700000,265.270000,265.270000,692919,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-24,264.110000,266.110000,261.620000,265.360000,265.360000,526623,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-26,262.515000,269.130000,261.490000,262.060000,262.060000,745398,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-29,263.540000,270.810000,262.540000,266.690000,266.690000,1341458,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-11-30,264.580000,265.350000,257.740000,259.130000,259.130000,1972791,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-01,260.450000,267.020000,259.120000,259.250000,259.250000,1090205,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-02,258.400000,263.420000,257.530000,262.730000,262.730000,1115763,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-03,265.110000,266.500000,258.330000,261.680000,261.680000,864153,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-06,262.550000,264.980000,259.240000,263.100000,263.100000,766295,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-07,267.480000,271.300000,265.190000,270.300000,270.300000,1086087,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-08,270.800000,272.930000,268.347700,272.190000,272.190000,888419,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-09,271.320000,272.800000,269.130000,269.160000,269.160000,563921,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-10,269.580000,271.970000,267.290000,270.320000,270.320000,713444,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-13,270.520000,272.000000,268.430000,269.740000,269.740000,800671,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-14,268.270000,269.220000,259.890000,262.650000,262.650000,789972,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-15,263.920000,268.770000,261.380000,268.100000,268.100000,836383,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-16,269.000000,271.550000,265.620000,266.450000,266.450000,906157,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-17,264.250000,269.667600,261.520000,267.430000,267.430000,1242171,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-20,266.580000,266.580000,260.580000,264.880000,264.880000,794743,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-21,265.880000,268.835000,262.440000,268.630000,268.630000,722227,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-22,269.440000,277.330000,269.440000,276.760000,276.760000,926914,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-23,277.640000,279.680000,276.880000,278.010000,278.010000,500438,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-27,281.170000,283.570000,279.110000,282.060000,282.060000,489378,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-28,283.090000,283.530000,279.640000,280.610000,280.610000,420076,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-29,279.480000,282.900000,279.160000,282.240000,282.240000,477379,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-30,282.700000,285.610000,281.910000,282.610000,282.610000,459556,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2021-12-31,281.580000,284.410000,281.580000,282.140000,282.140000,411172,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-03,282.100000,282.522000,268.550000,273.580000,273.580000,927978,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-04,272.620000,272.620000,264.030000,268.170000,268.170000,1111993,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-05,267.810000,269.120000,261.245000,261.610000,261.610000,1195420,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-06,260.000000,265.760000,257.150000,262.510000,262.510000,798119,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-07,262.190000,262.635000,254.860000,256.910000,256.910000,1364857,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-10,253.420000,257.390000,250.365900,257.230000,257.230000,979132,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-11,257.460000,261.175000,255.030000,260.290000,260.290000,659400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-12,261.080000,263.950000,260.235000,260.850000,260.850000,629291,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-13,259.890000,260.200000,251.650000,252.070000,252.070000,574984,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-14,250.420000,252.880000,241.520000,247.340000,247.340000,1217123,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-18,243.180000,245.580000,240.510000,242.320000,242.320000,838255,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-19,244.280000,246.322700,239.900000,240.280000,240.280000,587548,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-20,241.510000,249.510000,239.850000,244.400000,244.400000,1762345,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-21,245.000000,248.250000,239.920100,240.950000,240.950000,1108070,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-24,239.000000,244.310000,233.000000,243.700000,243.700000,1346078,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-25,237.710000,239.620000,233.010400,236.230000,236.230000,874824,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-26,238.150000,239.040000,230.060000,232.640000,232.640000,1141072,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-27,236.090000,237.160000,230.210000,232.000000,232.000000,679046,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-28,233.060000,238.990000,229.785000,238.820000,238.820000,819802,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-01-31,238.930000,245.700000,238.930000,244.900000,244.900000,1106506,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-01,247.260000,248.460000,242.190000,247.100000,247.100000,1028736,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-02,247.650000,255.720000,246.410000,254.450000,254.450000,1033157,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-03,250.000000,251.754000,248.420000,250.190000,250.190000,797825,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-04,248.530000,253.490000,246.460000,249.890000,249.890000,762806,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-07,249.890000,250.545000,244.910000,245.920000,245.920000,697576,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-08,243.380000,248.340000,242.340000,247.370000,247.370000,1135688,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-09,251.190000,255.800000,250.520000,255.570000,255.570000,1119552,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-10,249.720000,256.620000,248.940000,250.430000,250.430000,1457796,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-11,250.390000,253.580000,243.600000,244.280000,244.280000,1398155,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-14,243.520000,245.080000,238.180000,239.900000,239.900000,1347896,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-15,245.010000,245.010000,224.880000,228.640000,228.640000,3098099,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-16,228.420000,234.390000,223.800000,232.180000,232.180000,2573663,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-17,232.390000,233.810000,226.110000,226.360000,226.360000,1561106,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-18,227.370000,230.490000,224.650000,228.270000,228.270000,1288466,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-22,226.830000,230.220000,222.980000,226.460000,226.460000,1518514,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-23,227.990000,230.000000,222.980000,223.080000,223.080000,1172802,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-24,218.860000,229.440000,216.366400,228.470000,228.470000,2053032,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-25,229.420000,234.380000,227.850000,233.990000,233.990000,1257649,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-02-28,231.370000,233.030000,227.710000,230.120000,230.120000,1275730,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-01,231.100000,232.480000,226.295000,227.830000,227.830000,1077806,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-02,228.560000,235.140000,226.790000,232.370000,232.370000,912908,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-03,233.990000,235.700000,231.670000,233.370000,233.370000,923855,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-04,231.620000,231.830000,225.750000,227.000000,227.000000,1149232,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-07,223.870000,224.680000,215.420000,216.660000,216.660000,1388836,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-08,214.900000,216.990000,208.610000,210.560000,210.560000,2040822,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-09,216.310000,221.080000,215.030000,219.210000,219.210000,1440060,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-10,215.740000,218.340000,214.535000,216.940000,216.940000,795354,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-11,219.300000,219.930000,213.320000,213.610000,213.610000,572504,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-14,215.050000,218.800000,209.935000,211.090000,211.090000,994418,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-15,214.200000,216.210000,213.070000,215.010000,215.010000,748154,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-16,218.850000,223.650000,215.040000,220.270000,220.270000,1280546,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-17,219.550000,223.250000,218.670000,223.240000,223.240000,909473,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-18,223.320000,228.240000,221.970000,227.660000,227.660000,1311552,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-21,224.780000,229.990000,224.780000,226.970000,226.970000,1244325,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-22,226.670000,231.210000,226.420000,228.930000,228.930000,959544,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-23,226.990000,227.920000,219.020000,220.310000,220.310000,849051,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-24,220.890000,224.650000,219.185000,224.620000,224.620000,664026,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-25,225.800000,226.980000,219.950000,224.760000,224.760000,703338,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-28,225.410000,226.710000,223.820000,226.690000,226.690000,562621,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-29,231.400000,234.710000,230.285000,233.590000,233.590000,994545,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-30,232.600000,235.000000,229.950000,231.320000,231.320000,1108442,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-03-31,231.670000,235.180000,230.260000,231.210000,231.210000,1191750,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-01,232.920000,240.580000,232.615000,240.310000,240.310000,1399562,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-04,240.370000,241.710000,237.080000,238.500000,238.500000,1262247,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-05,237.560000,241.550000,236.090000,238.360000,238.360000,945461,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-06,236.470000,241.400000,234.430100,240.300000,240.300000,947733,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-07,239.960000,251.600000,239.395000,249.280000,249.280000,1396242,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-08,248.510000,254.940000,248.510000,252.290000,252.290000,1501760,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-11,249.310000,251.790000,242.570000,242.980000,242.980000,1015826,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-12,243.880000,246.350000,235.300000,237.670000,237.670000,1237684,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-13,236.630000,239.950000,236.080000,239.310000,239.310000,897169,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-14,240.120000,241.650000,235.270000,238.480000,238.480000,931214,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-18,238.830000,239.160000,232.520000,234.390000,234.390000,653877,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-19,233.770000,238.565000,233.770000,237.870000,237.870000,687103,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-20,239.700000,245.200000,238.630000,242.770000,242.770000,759823,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-21,245.230000,245.370000,235.390000,236.170000,236.170000,733839,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-22,234.010000,234.430000,227.925000,228.160000,228.160000,1010656,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-25,223.450000,223.450000,216.140000,219.860000,219.860000,1480126,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-26,217.990000,218.790000,205.030000,206.730000,206.730000,2113281,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-27,215.000000,218.000000,204.500000,210.240000,210.240000,2570408,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-28,212.530000,220.515000,209.080000,219.400000,219.400000,2300013,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-04-29,222.320000,228.285000,217.530000,217.990000,217.990000,1818450,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-02,215.520000,218.200000,211.300000,217.060000,217.060000,1327502,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-03,217.290000,220.540000,214.850000,215.200000,215.200000,1093534,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-04,214.730000,223.730000,212.010000,222.790000,222.790000,1274514,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-05,221.320000,222.340000,213.100000,215.320000,215.320000,859096,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-06,213.830000,214.720000,210.050000,213.820000,213.820000,936224,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-09,210.640000,212.040000,203.200000,204.070000,204.070000,1239742,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-10,207.030000,208.670000,199.670000,203.210000,203.210000,1309427,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-11,203.050000,208.110000,200.450000,200.960000,200.960000,1097881,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-12,198.990000,205.140000,198.110100,202.530000,202.530000,1066979,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-13,205.640000,211.220000,204.290000,208.710000,208.710000,695400,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-16,206.600000,209.480000,203.850000,206.450000,206.450000,619231,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-17,209.060000,211.150000,204.500000,206.690000,206.690000,1025233,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-18,204.110000,205.740000,195.810000,197.260000,197.260000,1217510,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-19,196.200000,203.370000,195.570000,201.740000,201.740000,1398588,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-20,204.500000,204.660000,197.525000,201.830000,201.830000,861542,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-23,203.900000,204.240000,199.420000,203.390000,203.390000,723053,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-24,204.400000,204.400000,199.630000,201.990000,201.990000,779845,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-25,201.900000,205.310000,199.690000,203.340000,203.340000,866675,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-26,203.640000,208.680000,203.640000,207.730000,207.730000,850077,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-27,208.810000,220.730000,208.590000,220.500000,220.500000,1713080,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-05-31,216.620000,217.740000,212.220000,215.250000,215.250000,1604317,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-01,216.050000,217.020000,208.295000,210.110000,210.110000,910474,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-02,210.250000,220.300000,209.480000,220.060000,220.060000,871511,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-03,217.200000,221.170000,216.390000,219.440000,219.440000,987244,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-06,221.310000,223.200000,219.310000,220.790000,220.790000,585204,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-07,219.120000,225.750000,219.120000,225.230000,225.230000,761548,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-08,222.000000,224.730000,218.940000,220.710000,220.710000,636026,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-09,219.010000,220.300000,216.320000,216.650000,216.650000,800683,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-10,213.110000,214.410000,207.050000,207.370000,207.370000,959669,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-13,200.220000,203.920000,199.085000,200.300000,200.300000,1219772,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-14,199.710000,202.000000,195.760000,200.880000,200.880000,1182722,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-15,204.100000,205.950000,198.845000,202.130000,202.130000,1234038,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-16,198.090000,198.495000,194.670000,196.450000,196.450000,1535895,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-17,195.960000,200.760000,194.850000,196.950000,196.950000,1785717,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-21,200.130000,202.570000,197.345000,198.770000,198.770000,1543884,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-22,196.830000,204.160000,196.190000,201.740000,201.740000,1620946,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-23,202.520000,212.530000,202.520000,211.540000,211.540000,1418827,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-24,214.130000,215.290000,212.240000,213.800000,213.800000,2735773,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-27,214.050000,216.990000,212.270000,216.510000,216.510000,746288,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-28,216.210000,217.616500,210.730000,212.210000,212.210000,747310,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-29,212.060000,215.530000,210.400000,214.110000,214.110000,1143234,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-06-30,211.270000,220.280000,211.270000,216.990000,216.990000,1811578,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-01,217.260000,218.220000,211.500000,215.050000,215.050000,856325,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-05,211.680000,215.410000,208.280000,215.310000,215.310000,775334,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-06,216.070000,218.870000,214.890000,216.000000,216.000000,758431,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-07,214.330000,219.030000,214.330000,218.850000,218.850000,809264,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-08,217.460000,221.610000,216.760000,219.340000,219.340000,580910,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-11,217.350000,219.680000,216.478000,217.400000,217.400000,517521,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-12,217.180000,219.800000,211.940000,213.530000,213.530000,613167,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-13,209.370000,213.930000,208.380000,211.830000,211.830000,533078,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-14,209.000000,212.430000,206.260000,212.000000,212.000000,877064,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-15,216.010000,219.130000,214.070000,219.080000,219.080000,1016717,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-18,220.240000,220.390000,212.130000,212.870000,212.870000,863653,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-19,216.050000,221.190000,214.885000,220.500000,220.500000,1076363,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-20,220.980000,222.620000,219.275000,220.600000,220.600000,1089729,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-21,219.000000,227.420000,215.390000,225.630000,225.630000,1639506,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-22,227.130000,227.130000,220.060000,221.740000,221.740000,839919,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-25,221.480000,223.170000,219.195000,221.620000,221.620000,747785,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-26,221.310000,221.670000,215.110000,219.680000,219.680000,995853,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-27,219.440000,226.860000,218.665000,225.130000,225.130000,907799,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-28,226.530000,236.265000,225.205000,236.010000,236.010000,1315396,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-07-29,235.990000,240.820000,234.750000,240.270000,240.270000,2125206,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-01,238.930000,241.855000,237.185000,238.370000,238.370000,1415053,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-02,236.010000,237.505000,229.630000,233.410000,233.410000,989816,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-03,233.940000,234.690000,228.590000,233.210000,233.210000,864147,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-04,233.190000,236.000000,232.237700,234.340000,234.340000,637747,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-05,232.040000,234.975000,230.290000,234.740000,234.740000,678106,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-08,236.030000,237.420000,233.230000,233.660000,233.660000,498330,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-09,234.110000,235.410000,231.490000,232.600000,232.600000,562335,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-10,236.890000,240.040000,236.860000,239.690000,239.690000,572747,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-11,241.440000,244.700000,240.005000,242.000000,242.000000,1995168,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-12,242.200000,246.032000,240.815000,245.810000,245.810000,878893,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-15,244.750000,249.110000,244.270000,248.260000,248.260000,959607,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-16,246.020000,246.645000,243.020000,244.710000,244.710000,884863,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-17,242.530000,244.155000,239.865000,240.620000,240.620000,521081,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-18,241.020000,241.870000,237.290000,238.820000,238.820000,422242,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-19,237.920000,239.480000,236.310000,239.020000,239.020000,573489,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-22,234.920000,236.860000,231.160000,231.570000,231.570000,702132,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-23,230.340000,231.790000,228.380000,229.240000,229.240000,806048,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-24,230.190000,232.190000,229.070000,231.830000,231.830000,467576,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-25,234.980000,234.980000,231.035000,234.730000,234.730000,536165,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-26,235.000000,235.000000,219.620000,219.670000,219.670000,857708,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-29,218.490000,220.610000,216.850000,218.210000,218.210000,712145,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-30,218.810000,219.030000,214.640000,215.990000,215.990000,613159,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-08-31,217.290000,218.890000,211.830000,212.660000,212.660000,1116575,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-01,211.720000,211.760000,207.310000,211.620000,211.620000,921874,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-02,214.100000,214.100000,206.500000,207.260000,207.260000,862836,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-06,207.470000,210.520000,206.210000,209.660000,209.660000,882762,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-07,209.440000,215.650000,206.790000,215.140000,215.140000,757499,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-08,214.070000,221.330000,212.680000,221.120000,221.120000,932807,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-09,221.140000,224.650000,219.340000,223.170000,223.170000,623765,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-12,224.410000,227.630000,223.545000,226.740000,226.740000,563148,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-13,219.890000,221.220000,212.060000,212.510000,212.510000,1169080,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-14,213.710000,214.430000,207.080000,209.130000,209.130000,864111,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-15,209.690000,211.140000,206.480000,207.370000,207.370000,762159,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-16,205.710000,205.710000,201.660000,205.040000,205.040000,1516085,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-19,203.340000,203.980000,200.510000,203.700000,203.700000,916120,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-20,201.900000,202.500000,197.780000,199.660000,199.660000,740371,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-21,201.450000,203.430000,195.320000,195.520000,195.520000,733456,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-22,194.320000,194.355000,190.460000,190.620000,190.620000,891205,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-23,188.780000,191.205000,186.240000,189.430000,189.430000,1244179,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-26,188.310000,190.590000,185.930000,186.080000,186.080000,1262629,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-27,188.010000,190.000000,182.028400,182.890000,182.890000,1968601,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-28,185.010000,186.760000,182.590000,185.690000,185.690000,1652721,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-29,183.840000,183.840000,180.160000,181.610000,181.610000,1648978,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-09-30,182.460000,187.500000,180.580000,181.140000,181.140000,2043323,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-03,184.240000,187.960000,181.060000,186.200000,186.200000,1036005,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-04,189.970000,193.215000,189.660000,193.100000,193.100000,1072927,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-05,190.100000,193.925000,187.240000,192.490000,192.490000,952729,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-06,191.280000,192.310000,187.170000,187.540000,187.540000,1082495,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-07,184.605000,184.880000,178.780000,180.340000,180.340000,1200474,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-10,180.880000,180.960000,174.410000,175.910000,175.910000,946156,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-11,174.260000,175.040000,170.325000,172.450000,172.450000,1373105,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-12,173.830000,174.250000,171.840000,171.860000,171.860000,864660,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-13,167.130000,178.190000,165.750000,176.210000,176.210000,1266221,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-14,177.920000,179.180000,172.840000,173.410000,173.410000,1018500,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-17,176.720000,181.940000,176.280000,181.180000,181.180000,1093637,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-18,185.270000,187.890000,182.490000,184.330000,184.330000,962522,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-19,181.390000,181.940000,176.500000,178.390000,178.390000,967124,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-20,178.810000,180.420000,174.280000,174.580000,174.580000,1045373,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-21,173.810000,178.360000,171.240000,178.150000,178.150000,1409796,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-24,180.010000,181.580000,176.770000,179.560000,179.560000,1156125,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-25,188.430000,197.830000,188.430000,197.650000,197.650000,2616619,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-26,192.550000,204.680000,188.620000,202.100000,202.100000,2410419,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-27,202.000000,205.885000,199.810000,200.420000,200.420000,1804076,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-28,201.320000,208.960000,200.550000,208.160000,208.160000,1580011,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-10-31,206.030000,210.075000,205.950000,209.670000,209.670000,1812990,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-01,211.360000,213.500000,206.740000,209.390000,209.390000,881969,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-02,208.440000,212.510000,204.250000,204.350000,204.350000,1040309,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-03,201.300000,205.755000,198.070000,203.860000,203.860000,918881,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-04,205.730000,206.860000,200.420000,204.100000,204.100000,1096809,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-07,205.060000,208.131700,203.005000,207.990000,207.990000,738311,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-08,208.650000,211.920000,206.590000,207.920000,207.920000,636521,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-09,206.470000,208.870000,203.960000,204.310000,204.310000,577189,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-10,214.670000,222.815000,213.420000,222.580000,222.580000,799676,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-11,222.500000,228.980000,222.450000,226.530000,226.530000,1011075,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-14,224.950000,227.380000,222.300000,222.360000,222.360000,828330,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-15,226.790000,227.990000,222.240000,224.310000,224.310000,809402,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-16,223.720000,225.445000,220.510000,224.020000,224.020000,592635,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-17,221.000000,221.000000,209.435000,211.420000,211.420000,1497576,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-18,215.360000,215.360000,209.900000,213.780000,213.780000,891813,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-21,212.670000,215.690600,210.880000,214.900000,214.900000,755165,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-22,217.070000,217.100000,212.750000,215.900000,215.900000,1038171,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-23,216.770000,219.460000,215.450000,217.720000,217.720000,318583,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-25,218.600000,220.425000,217.825000,219.980000,219.980000,253521,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-28,220.280000,222.060000,213.500000,214.450000,214.450000,901554,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-29,213.860000,215.690000,209.710000,212.500000,212.500000,1682041,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-11-30,214.580000,218.260000,207.410000,218.020000,218.020000,2027490,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-01,220.950000,222.870000,218.300000,220.550000,220.550000,846057,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-02,216.130000,219.040000,214.090000,217.730000,217.730000,880475,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-05,214.240000,215.170000,209.650000,211.930000,211.930000,987804,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-06,211.460000,214.470000,207.050000,209.870000,209.870000,867048,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-07,208.330000,211.650000,205.790000,207.690000,207.690000,1298526,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-08,208.140000,211.260000,206.380000,210.410000,210.410000,1124044,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-09,209.690000,212.160000,208.190000,208.530000,208.530000,791527,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-12,209.630000,213.470000,207.970000,213.140000,213.140000,772102,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-13,221.000000,223.140000,214.590000,216.800000,216.800000,1136592,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-14,215.820000,218.280000,212.440000,214.210000,214.210000,1347412,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-15,210.560000,212.400000,206.985000,208.410000,208.410000,1087870,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-16,205.500000,207.160000,202.750000,203.780000,203.780000,1346121,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-19,203.270000,203.270000,199.210000,199.840000,199.840000,815977,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-20,199.070000,202.440000,197.150000,201.380000,201.380000,967124,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-21,203.280000,205.820000,202.070000,204.550000,204.550000,811572,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-22,202.050000,204.190000,199.765000,203.140000,203.140000,592812,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-23,202.380000,204.510000,201.580000,203.840000,203.840000,368273,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-27,203.730000,204.680000,201.050000,202.940000,202.940000,493395,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-28,203.640000,206.410000,201.860000,201.870000,201.870000,346211,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-29,204.360000,208.850000,203.665000,207.810000,207.810000,456250,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
2022-12-30,205.970000,205.970000,202.070000,204.890000,204.890000,514507,0.000000,1.000000,IQV,Common Stock,IQVIA Holdings Inc,"IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.",1478242,NYSE,USD,USA,TRADE & SERVICES,SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH,"4820 EMPEROR BLVD., DURHAM, NC, US",https://www.iqvia.com,December,2025-03-31,28413522000,2926000000,22.41,1.015,34.33,None,None,7.33,86.21,0.0861,0.137,0.053,0.216,15497000000,5380000000,7.33,-0.103,0.025,189.65,3,14,7,0,0,22.41,13.85,1.833,4.754,2.648,11.95,1.286,252.88,134.65,150.74,187.95,173000000,164478000,0.961,95.590,None,None
